10.01.2013 Views

e xhibit ors list of exhibitors in alphabetical - ERA-EDTA Congress ...

e xhibit ors list of exhibitors in alphabetical - ERA-EDTA Congress ...

e xhibit ors list of exhibitors in alphabetical - ERA-EDTA Congress ...

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

EXHIBITORS<br />

394<br />

49 th <strong>ERA</strong>-<strong>EDTA</strong> CONGRESS<br />

E X H I B I T O R S<br />

LIST OF EXHIBITORS<br />

IN ALPHABETICAL ORDER<br />

Companies are totally responsible for the description below<br />

Abbott .............................................Booth 2.03+2.90+2.88<br />

Abbott is a global, broad-based health care company<br />

devoted to the discovery, development, manufacture<br />

and market<strong>in</strong>g <strong>of</strong> pharmaceuticals and medical products,<br />

<strong>in</strong>clud<strong>in</strong>g nutritionals, devices and diagnostics.<br />

Our commitment to kidney care and kidney patients<br />

stretches back more than two decades and extends<br />

across our pharmaceutical, nutritional, diagnostic and<br />

vascular divisions. We produce and market a wide<br />

range <strong>of</strong> products that benefit kidney disease patients<br />

<strong>in</strong> more than 130 countries around the world today,<br />

and have an <strong>in</strong>dustry-lead<strong>in</strong>g pipel<strong>in</strong>e focused on<br />

br<strong>in</strong><strong>in</strong>g cont<strong>in</strong>ued <strong>in</strong>novation to patients tomorrow.<br />

Abbott <strong>in</strong>formation is available on the company’s<br />

websites at www.abbott.com<br />

Actual Way Medical Devices -<br />

Via Actual ........................................................ Booth 2.21<br />

We are ActualWay ® , a Portuguese manufacturer <strong>of</strong><br />

care treatment medical equipment such as Therapy,<br />

Sampl<strong>in</strong>g/Blood Donation, Gynaecological, Multifunctional<br />

Chairs, Couches and many accessories.<br />

We have been <strong>in</strong>creas<strong>in</strong>g our distribution all over the<br />

world thanks to big efforts <strong>in</strong> promot<strong>in</strong>g our products.<br />

Our sales strategy is based on build<strong>in</strong>g a long term relationship<br />

with all our partners provid<strong>in</strong>g quality and<br />

service. The best way to take care is to get our partners´<br />

and patients´ satisfaction meet<strong>in</strong>g their needs.<br />

We produce reliable, strong and comfortable products<br />

because we do care. Come and jo<strong>in</strong> us so that we can<br />

expand bus<strong>in</strong>ess together!<br />

www.actualway.pt<br />

w w w . e r a e d t a 2 0 1 2 . o r g


MAY 24-27, 2012 PARIS, France<br />

E X H I B I T O R S<br />

Alam Medical ............................................... Booth 1.64A<br />

Alam Medical, a French company, develops, manufactures<br />

and markets high-tech medical products with<br />

particular focus on cardiovascular diagnosis with the<br />

Compliorr device. Complior AnalyseR measures aortic<br />

stiffness with the reference methodology: simultaneous<br />

carotid-femoral pulse wave velocity (PWV).<br />

Compliorr is the device used <strong>in</strong> most epidemiological<br />

studies which made PWV a recognized measurement<br />

<strong>of</strong> organ damage <strong>in</strong> the ESH guidel<strong>in</strong>es. The latest distance<br />

methodology and the <strong>in</strong>ternational PWV reference<br />

values are <strong>in</strong>cluded <strong>in</strong> Compliorr Analyse for a<br />

rapid and easy <strong>in</strong>terpretation <strong>of</strong> the results. With the<br />

Compliorr Analyse, it is possible to assess central pressure<br />

from a carotidogram. The measurement is handsfree<br />

and done dur<strong>in</strong>g the PWV measurement with no<br />

additional time. With Compliorr Analyse, you have<br />

the reference gold standard PWV and carotid central<br />

pressure analysis <strong>in</strong> a s<strong>in</strong>gle acquisition.<br />

www.complior.com<br />

Alere International ......................................... Booth 1.93<br />

By develop<strong>in</strong>g new capabilities <strong>in</strong> near-patient diagnosis,<br />

monitor<strong>in</strong>g and health management, Alere Inc.<br />

(formerly Inverness Medical Innovations, Inc.) enables<br />

<strong>in</strong>dividuals to take charge <strong>of</strong> improv<strong>in</strong>g their health<br />

and quality <strong>of</strong> life. Alere’s global lead<strong>in</strong>g products<br />

and services, as well as its new product development<br />

efforts, focus on <strong>in</strong>fectious disease, cardiology, oncology,<br />

drugs <strong>of</strong> abuse and women’s health. For more <strong>in</strong>formation<br />

about Alere, please visit at www.alere.com<br />

Alexion Pharma International ........ Booths 1.26+1.116<br />

Alexion Pharmaceuticals is a global biopharmaceutical<br />

company focused on serv<strong>in</strong>g patients with severe and<br />

ultra-rare disorders through the <strong>in</strong>novation, development<br />

and commercialization <strong>of</strong> life-transform<strong>in</strong>g therapeutic<br />

products. Alexion is the global leader <strong>in</strong> complement<br />

<strong>in</strong>hibition, and has developed and markets<br />

Soliris ® (eculizumab) as a treatment for patients with<br />

PNH and aHUS. Alexion is evaluat<strong>in</strong>g other potential<br />

<strong>in</strong>dications for Soliris and is develop<strong>in</strong>g four other<br />

highly <strong>in</strong>novative biotechnology product candidates.<br />

www.alxn.com<br />

w w w . e r a e d t a 2 0 1 2 . o r g<br />

395<br />

EXHIBITORS


EXHIBITORS<br />

396<br />

49th <strong>ERA</strong>-<strong>EDTA</strong> CONGRESS<br />

E X HPI OB IS T OE R S<br />

Allmed Medical ............................................. Booth 2.27<br />

Allmed Medical GmbH is a vertically <strong>in</strong>tegrated manufacturer,<br />

provid<strong>in</strong>g the latest world-class standards<br />

<strong>in</strong> dialysis products. Allmed’s lead<strong>in</strong>g dialyzer brand,<br />

Polypurer <strong>in</strong>corporates a new proprietary Polysulfone<br />

membrane, with outstand<strong>in</strong>g performances <strong>in</strong> both efficiency<br />

and biocompatibility aspects. The membrane<br />

is unique for its unprecedented Micro-Undulation<br />

Technology. Allmed and its partners are committed<br />

to <strong>of</strong>fer customised solutions to pr<strong>of</strong>essionals and patients<br />

<strong>in</strong> Hemodialysis. Capitaliz<strong>in</strong>g on its long experience<br />

<strong>in</strong> the field <strong>of</strong> hemodialysis, Allmed is able to give<br />

personalised service and assistance to its customers.<br />

www.allmedgrp.com<br />

Amgen Europe .................................................. Booth 2.48<br />

Amgen discovers, develops and delivers <strong>in</strong>novative<br />

human therapeutics. A biotechnology pioneer s<strong>in</strong>ce<br />

1980 and the orig<strong>in</strong>ator <strong>of</strong> recomb<strong>in</strong>ant ESAs, Amgen<br />

was one <strong>of</strong> the first companies to realize the new science’s<br />

promise by br<strong>in</strong>g<strong>in</strong>g novel medic<strong>in</strong>es from lab,<br />

to manufactur<strong>in</strong>g plant, to patient. Amgen therapeutics<br />

have changed the practice <strong>of</strong> medic<strong>in</strong>e, help<strong>in</strong>g millions<br />

<strong>of</strong> people <strong>in</strong> the fight aga<strong>in</strong>st cancer, kidney disease,<br />

rheumatoid arthritis and other serious illnesses. With<br />

a broad and deep pipel<strong>in</strong>e <strong>of</strong> potential new medic<strong>in</strong>es,<br />

Amgen rema<strong>in</strong>s committed to advanc<strong>in</strong>g<br />

science to dramatically improve people’s lives. June<br />

2011 marks 10 years s<strong>in</strong>ce the launch <strong>of</strong> Aranesp ® (darbepoet<strong>in</strong><br />

alfa) and 5 years s<strong>in</strong>ce the <strong>in</strong>troduction <strong>of</strong> the<br />

world’s firstgen. calcimimetic, Mimpara ® . We <strong>in</strong>vite<br />

you to come and celebrate with us on booth 2.02, level 2.<br />

www.amgen.com<br />

Arbor Research .............................................. Booth 1.G7<br />

Arbor Research is a not-for-pr<strong>of</strong>it research organization<br />

based <strong>in</strong> Ann Arbor, Michigan, USA, conduct<strong>in</strong>g<br />

large studies <strong>in</strong> epidemiology and public health. With<br />

particular expertise <strong>in</strong> biostatistical analysis, cl<strong>in</strong>ical<br />

practice, the management and <strong>in</strong>tegration <strong>of</strong> large data<br />

sets, economics, and public policy, Arbor Research engages<br />

<strong>in</strong> health outcomes research on chronic disease<br />

and end-stage organ failure, currently <strong>in</strong>clud<strong>in</strong>g the<br />

<strong>in</strong>ternational Dialysis Outcomes and Practice Patterns<br />

Study. www.dopps.org<br />

w w w . e r a e d t a 2 0 1 2 . o r g


MAY 24-27, 2012 PARIS, France<br />

E X H I B I T O R S<br />

Asahi Kasei Medical Europe ............. Booths 1.42+1.47<br />

Asahi Kasei Medical is a world leader <strong>in</strong> research, development,<br />

and production <strong>of</strong> devices and systems for<br />

blood treatment and purification based on advanced<br />

membrane separation and adsorption technologies. It<br />

serves the global market with haemodialysis, therapeutic<br />

apheresis, and blood transfusion products. Information<br />

about Asahi’s membranes, adsorbents and<br />

full range <strong>of</strong> products can be found on our website at:<br />

www.asahikasei-medical.com<br />

Atcor Medical ............................................... Booth 1.G23<br />

AtCor Medical’s SphygmoCor ® systems, featured <strong>in</strong><br />

over 2000 published studies, are the global gold standard<br />

for non<strong>in</strong>vasive central blood pressure/arterial<br />

stiffness assessment. Major studies have found:<br />

-- Elevated central pressure is a superior <strong>in</strong>dependent<br />

predictor <strong>of</strong> CV risk<br />

-- 70% <strong>of</strong> patients with high normal blood pressure<br />

had central pressures equivalent with those <strong>of</strong> patients<br />

with Stage 1 Hypertension<br />

--Patients with central pulse pressure ≥ 50mmHg are<br />

at significantly higher risk for cardiovascular events.<br />

Visit us for a complementary central pressures assessment.<br />

www.atcormedical.com<br />

Atlantic Biomedical ....................................... Booth 2.04<br />

Atlantic Biomedical P. Ltd. is an overrid<strong>in</strong>g organization<br />

<strong>in</strong>corporated <strong>in</strong> the year 2008 by the jo<strong>in</strong>t efforts<br />

<strong>of</strong> Mr. Ravi Vazirani & Mr. Sunil Vazirani <strong>in</strong> the doma<strong>in</strong><br />

<strong>of</strong> dialysis related products and services. Atlantic<br />

Biomedical P. Ltd. is engaged <strong>in</strong> the manufactur<strong>in</strong>g <strong>of</strong><br />

medical equipments whereas Atlantic Pharmaceuticals<br />

(<strong>in</strong>corporated <strong>in</strong> the year 1987) is engaged <strong>in</strong> the<br />

manufactur<strong>in</strong>g and market<strong>in</strong>g <strong>of</strong> licensed drug products.<br />

Ours is an ISO 13485-2003 certified company and<br />

have dist<strong>in</strong>ction <strong>of</strong> be<strong>in</strong>g the first manufactures <strong>of</strong><br />

Dialyzer Reprocess<strong>in</strong>g Mach<strong>in</strong>e RENACLEAN ® , Cold<br />

Sterilant RENACLEAN ® , Hot Dis<strong>in</strong>fectant RENAS-<br />

TERIL ® , Acid Concentrate CITRACON ® , Calcium Acetate<br />

LOW-PHOS ® tablets <strong>in</strong> India. Apart from what<br />

we are one <strong>of</strong> the lead<strong>in</strong>g Dialysis Fluid Manufacturers<br />

<strong>in</strong> the country like Bicarbonate, Acetic, Na, K, Calcium<br />

Free & Citric Acid Concentrate.<br />

w w w . e r a e d t a 2 0 1 2 . o r g<br />

397<br />

EXHIBITORS


EXHIBITORS<br />

398<br />

49th <strong>ERA</strong>-<strong>EDTA</strong> CONGRESS<br />

E X H I B I T O R S<br />

Awak Technologies ....................................... Booth 1.68<br />

Awak is develop<strong>in</strong>g the world’s first wearable dialysis<br />

mach<strong>in</strong>e target<strong>in</strong>g ESRD patients. Our Vision is to create<br />

a new paradigm <strong>in</strong> renal dialysis. It is different from<br />

current dialysis mach<strong>in</strong>es <strong>in</strong> the market, as it provides<br />

patients with freedom dur<strong>in</strong>g their treatment. With<br />

Awak weigh<strong>in</strong>g only 1kg and the ability to regenerate<br />

spent dialysate, it now substitutes the major functions<br />

<strong>of</strong> a kidney by constantly remov<strong>in</strong>g tox<strong>in</strong>s and waste<br />

materials, and excessive fluid from the patient’s body.<br />

This new technology not only have and susta<strong>in</strong> ESRD<br />

patients, but also enhances their lives, br<strong>in</strong>g<strong>in</strong>g them<br />

comfort and convenience. www.awak.com<br />

B.Braun Avitum .............................................. Booth 2.12<br />

Always with Passion.<br />

B. Braun Avitum is a lead<strong>in</strong>g provider <strong>of</strong> dialysis care<br />

products. The B. Braun Avitum product range <strong>in</strong>cludes<br />

dialysis mach<strong>in</strong>es and dialysis consumables for<br />

chronic and acute dialysis as well as a comprehensive<br />

product portfolio for special blood cleans<strong>in</strong>g processes<br />

to treat conditions such as lipid metabolic disorders. B.<br />

Braun Avitum manufactures top quality dialysis mach<strong>in</strong>es,<br />

dialyzers (e.g. xevonta) and disposables.<br />

www.bbraun.com<br />

Ba<strong>in</strong> Medical Equipment ............................. Booth 1.22<br />

Ba<strong>in</strong> Medical Equipment (Guangzhou) Co., Ltd. was<br />

established <strong>in</strong> 2003 specialized <strong>in</strong> research<strong>in</strong>g, develop<strong>in</strong>g,<br />

manufactur<strong>in</strong>g and distribut<strong>in</strong>g <strong>of</strong> medical<br />

equipment and medical macromolecule products.<br />

We have strong technical strength, compris<strong>in</strong>g an experienced<br />

team with expertise and high technologies<br />

from Europe and Japan. Hav<strong>in</strong>g <strong>in</strong>troduced advanced<br />

manufactur<strong>in</strong>g and <strong>in</strong>spect<strong>in</strong>g facilities, we are able to<br />

perform dynamic monitor<strong>in</strong>g cover<strong>in</strong>g full process <strong>of</strong><br />

materials purchase, production and f<strong>in</strong>ished products.<br />

Presently Ba<strong>in</strong> specializes <strong>in</strong> manufactur<strong>in</strong>g and distribut<strong>in</strong>g<br />

hemodialyzer, tub<strong>in</strong>g sets for hemodialysis,<br />

disposable AV fistula needle sets, and tub<strong>in</strong>g disposables<br />

for hemodialysis, all with lead<strong>in</strong>g technologies <strong>in</strong><br />

the <strong>in</strong>dustry. ISO9001, ISO13485, CE and CCC certification<br />

passed. www.ba<strong>in</strong>medical.com<br />

w w w . e r a e d t a 2 0 1 2 . o r g


MAY 24-27, 2012 PARIS, France<br />

E X H I B I T O R S<br />

Baxter Healthcare ........................................... Booth 2.39<br />

Baxter International Inc’s Renal franchise is a leader <strong>in</strong><br />

renal home therapies through its products for Peritoneal<br />

Dialysis (PD), provid<strong>in</strong>g PD solutions <strong>in</strong>clud<strong>in</strong>g<br />

Low Glucose, devices, related supplies and services<br />

to help end-stage kidney disease patients perform dialysis<br />

treatment <strong>in</strong> the home. Baxter also distributes<br />

products and provides support services for Cont<strong>in</strong>uous<br />

Renal Replacement Therapy (CRRT), an acute,<br />

hospital-based therapy, and distributes products for<br />

In-Center Hemodialysis (HD). Baxter, <strong>in</strong> partnership<br />

with DEKA Research and Development Corporation,<br />

is develop<strong>in</strong>g <strong>in</strong>novative technologies aimed at<br />

employ<strong>in</strong>g a compact design and convenient use for<br />

patients, such as a new automated PD cycler and High<br />

Dose HD technology platform. www.baxter.com<br />

Bellco .............................................................Hall Maillot<br />

Bellco, with over 40 years’ experience, operates worldwide<br />

<strong>of</strong>fer<strong>in</strong>g therapies and systems for blood purification<br />

<strong>in</strong> Dialysis, Intensive Care and Cardiology,<br />

with <strong>in</strong>creased focus on personalized treatments for<br />

critical patients. Bellco stands out for the Collaborative<br />

Research <strong>in</strong> the treatment <strong>of</strong> renal failure, multiple organ<br />

failure, sepsis and congestive heart failure, with<br />

the goal <strong>of</strong> shar<strong>in</strong>g know-how and <strong>in</strong>novation with the<br />

scientific and medical communities. Upon these premises,<br />

Bellco provides its contribution to the Collaborative<br />

Research Club. Biocompatibility, cardiovascular<br />

stability, nutritional state and clearance efficiency are<br />

the lead<strong>in</strong>g challenges for Bellco’s Therapeutic Dialysis:<br />

constant research and <strong>in</strong>novation for personalised<br />

solutions. Complex cl<strong>in</strong>ical conditions, such as those<br />

<strong>of</strong> patients <strong>in</strong> Intensive Care, undergo<strong>in</strong>g surgery,<br />

with multiple traumas, sepsis, multi-organ failure,<br />

cardiopathy, affected by immune pathologies and <strong>in</strong>toxication,<br />

require <strong>in</strong>tegrated therapeutic approaches<br />

capable <strong>of</strong> assur<strong>in</strong>g versatility, functionality and effectiveness.<br />

The Bellco’s all-embrac<strong>in</strong>g <strong>of</strong>fer for all these<br />

pathologies provides a completely new outlook on<br />

Acute patients. www.bellco.net<br />

w w w . e r a e d t a 2 0 1 2 . o r g<br />

399<br />

EXHIBITORS


EXHIBITORS<br />

400<br />

49 th <strong>ERA</strong>-<strong>EDTA</strong> CONGRESS<br />

E X H I B I T O R S<br />

B<strong>in</strong>d<strong>in</strong>g Site ..................................................... Booth 1.05<br />

Visit stand 1.05 to learn more about polyclonal Freelite<br />

® serum free light cha<strong>in</strong> (FLC) measurement <strong>in</strong><br />

Acute Kidney Injury: “Clonal serum FLC can be measured<br />

with high sensitivity and specificity and used to<br />

rapidly screen for cast nephropathy. A susta<strong>in</strong>ed decrease<br />

<strong>in</strong> serum FLC levels with<strong>in</strong> 3 weeks <strong>of</strong> start<strong>in</strong>g<br />

treatment is associated with renal recovery”- Cockwell<br />

2010. Collect your copy <strong>of</strong> this paper and the Kidney<br />

<strong>in</strong> plasma cell dyscrasias book International Myeloma<br />

Work<strong>in</strong>g Group and NCCN ® guidel<strong>in</strong>es recommend<br />

use <strong>of</strong> serum free light cha<strong>in</strong> assays <strong>in</strong> the <strong>in</strong>itial diagnostic<br />

workup <strong>of</strong> Multiple Myeloma and related disorders.<br />

www.b<strong>in</strong>d<strong>in</strong>gsite.co.uk<br />

Bionic Mediz<strong>in</strong>technik ............................... Booth 1.103<br />

Bionic Mediz<strong>in</strong>technik with HQ <strong>in</strong> Friedrichsdorf near<br />

Frankfurt, Germany, is a specialised manufacturer <strong>of</strong><br />

products for dialysis s<strong>in</strong>ce 30 years. Our product range<br />

<strong>in</strong>cludes a large selection <strong>of</strong> dialysis fistula needles, dialysis<br />

catheters, therapy chairs and beds. Bionic dialysis<br />

fistula needles are lead<strong>in</strong>g <strong>in</strong> Europe and are sett<strong>in</strong>g<br />

new standards <strong>in</strong> quality and puncture characteristics.<br />

Bionic therapy chairs and beds are lead<strong>in</strong>g <strong>in</strong> performance<br />

and ergonomics. www.bionic-jms.com<br />

BioPorto Diagnostics .................................. Booth 1.G21<br />

The ability to diagnose acute kidney <strong>in</strong>jury (AKI) at an<br />

early time po<strong>in</strong>t is essential for improv<strong>in</strong>g the management<br />

and outcome <strong>of</strong> patients at risk <strong>of</strong> AKI. The novel<br />

biomarker NGAL has been shown to outperform current<br />

kidney status markers such as serum creat<strong>in</strong><strong>in</strong>e<br />

and cystat<strong>in</strong> C because it responds much earlier and<br />

shows a proportionate response to <strong>in</strong>jury. With The<br />

NGAL Test your hospital lab can measure NGAL<br />

<strong>in</strong> both plasma and ur<strong>in</strong>e samples on fully automated<br />

analyzers. www.bioporto.com<br />

w w w . e r a e d t a 2 0 1 2 . o r g


MAY 24-27, 2012 PARIS, France<br />

E X H I B I T O R S<br />

Bodystat........................................................... Booth 1.G6<br />

BODYSTAT ® are established as one <strong>of</strong> the global leaders<br />

<strong>in</strong> body composition analysis us<strong>in</strong>g Bioelectrical<br />

Impedance Analysis (BIA) technology. Complex<br />

changes occur <strong>in</strong> body composition and fluid status<br />

dur<strong>in</strong>g illness, renal failure and haemodialysis. Bodystat’s<br />

Multi-Frequency BIA technology can be used to<br />

assist <strong>in</strong> achiev<strong>in</strong>g Dry Weight, quickly, conveniently,<br />

without significant tra<strong>in</strong><strong>in</strong>g or education.<br />

See validation paper: Calf Bioimpedance Ratio Improves<br />

Dry Weight Assessment and Blood Pressure<br />

Control <strong>in</strong> Hemodialysis Patients. (Yi-Lun Zhou et al)<br />

Am J Nephrol 2010;32:109-116.<br />

www.bodystat.com<br />

Covidien ........................................................... Booth 1.37<br />

Covidien Vascular Therapies delivers a broad range<br />

<strong>of</strong> <strong>in</strong>novative non-<strong>in</strong>vasive and endovascular devices<br />

for the treatment <strong>of</strong> vascular disease worldwide. Covidien<br />

currently <strong>of</strong>fers cl<strong>in</strong>ically proven solutions for<br />

the prevention and treatment <strong>of</strong> deep ve<strong>in</strong> thrombosis<br />

(DVT), chronic venous <strong>in</strong>sufficiency, dialysis access,<br />

peripheral vascular disease, and neurovascular disease.<br />

Covidien develops new technologies, products<br />

and programs focused on improved patient outcomes<br />

and safer, more efficient healthcare practices throughout<br />

the cont<strong>in</strong>uum <strong>of</strong> care, across the globe.<br />

www.covidien.com<br />

Cybernius Medical ......................................... Booth 1.16<br />

Cybernius Medical Ltd. is committed to the effective<br />

utilization <strong>of</strong> proven lead<strong>in</strong>g edge technology <strong>in</strong> the<br />

Health Care Industry. CML focuses its resources on<br />

the development, sale, deployment and support <strong>of</strong> the<br />

cyberREN ® Renal Patient Care Management System<br />

for Nephrology. cyberREN ® is a comprehensive Electronic<br />

Medical Record (EMR), Cl<strong>in</strong>ical Data Analysis,<br />

and Report<strong>in</strong>g System for Nephrology. cyberREN ® is<br />

marketed and serviced by a team <strong>of</strong> dedicated cl<strong>in</strong>icians<br />

and <strong>in</strong>formation technologists. Also Available:<br />

cyberREN OFFICE, (Nephrologist Private Practice<br />

System) and cyberFUNDS (Bill<strong>in</strong>g for Nephrology)<br />

To contact a representative <strong>in</strong> your area call:<br />

1.800.276.8128 or visit our website at<br />

www.cyberren.com - email: <strong>in</strong>fo@cyberren.com<br />

w w w . e r a e d t a 2 0 1 2 . o r g<br />

401<br />

EXHIBITORS


EXHIBITORS<br />

402<br />

49 th <strong>ERA</strong>-<strong>EDTA</strong> CONGRESS<br />

E X H I B I T O R S<br />

Culligan ............................................................ Booth 1.94<br />

Culligan International is one <strong>of</strong> the longest-established,<br />

best-known companies <strong>in</strong> the water treatment sector,<br />

founded <strong>in</strong> Chicago <strong>in</strong> 1936. Culligan is a worldwide<br />

organization whose mission is water quality improvement.<br />

We have an extensive licensee distribution system<br />

<strong>in</strong> over 100 countries. Culligan manufactures a<br />

complete l<strong>in</strong>e <strong>of</strong> systems for dr<strong>in</strong>k<strong>in</strong>g water, as well as<br />

for many demand<strong>in</strong>g <strong>in</strong>dustrial applications: ultrafiltration,<br />

electro-deionisation, pharmaceutical <strong>in</strong>dustry,<br />

haemodialysis, food and beverage <strong>in</strong>dustry, electronics<br />

<strong>in</strong>dustry, which requires the highest purity water<br />

possible. www.culligan.it<br />

Debiotech ......................................................... Booth 1.92<br />

Debiotech is a Swiss, <strong>in</strong>dependent, high-tech medical<br />

device development company founded <strong>in</strong> 1989.<br />

Its core competence lies <strong>in</strong> the identification <strong>of</strong> breakthrough<br />

technologies and their development to market<br />

approval. These devices are then licensed to major<br />

<strong>in</strong>ternational pharmaceutical and medical device companies.<br />

DialEase TM is the lightest and smallest APD<br />

Cycler ever conceived for Homecare Peritoneal Dialysis,<br />

with an <strong>in</strong>novative approach to <strong>of</strong>fer more Quality<br />

and Safety for Patients, with full remote control by<br />

Nephrologists, while simplify<strong>in</strong>g daily use and transportation.<br />

www.debiotech.com<br />

Diaverum ......................................................... Booth 2.19<br />

At Diaverum, our mission is to improve the quality <strong>of</strong><br />

life for renal patients by revitalis<strong>in</strong>g them both physically<br />

and emotionally. Be<strong>in</strong>g one <strong>of</strong> the world’s lead<strong>in</strong>g<br />

renal care providers, Diaverum <strong>of</strong>fers a ho<strong>list</strong>ic<br />

approach, from preventive and early stage renal care<br />

to all renal replacement therapies. As a product <strong>in</strong>dependent<br />

provider – the largest <strong>in</strong> Europe - we are able<br />

to focus soley on car<strong>in</strong>g for the <strong>in</strong>dividual needs <strong>of</strong><br />

our patients. Our experience <strong>in</strong> renal care dates back<br />

20 years, when the first dialysis cl<strong>in</strong>ic was established,<br />

previously under our former name Gambro Healthcare.<br />

Today, 6,800 employees care for more than 20,000<br />

patients <strong>in</strong> 17 countries <strong>in</strong> Europe, Lat<strong>in</strong> America,<br />

Middle East and Australia. The corporate <strong>of</strong>fice <strong>of</strong> Diaverum<br />

is located <strong>in</strong> Munich, Germany, the head <strong>of</strong>fice<br />

is <strong>in</strong> Lund, Sweden. For more <strong>in</strong>formation visit<br />

www.diaverum.com.<br />

w w w . e r a e d t a 2 0 1 2 . o r g


MAY 24-27, 2012 PARIS, France<br />

E X H I B I T O R S<br />

Dir<strong>in</strong>co .............................................................. Booth 1.32<br />

The Dir<strong>in</strong>co Group is a Dutch and Swiss based company,<br />

with <strong>in</strong>novations ma<strong>in</strong>ly <strong>in</strong> the field <strong>of</strong> vascular<br />

access, hemotology, oncology and nephrology. Citra-<br />

Lock - catheter lock solution, anti-clott<strong>in</strong>g and antimicrobial<br />

is one <strong>of</strong> the <strong>in</strong>novations from Dir<strong>in</strong>co. The<br />

products are <strong>in</strong> a vial or prefilled syr<strong>in</strong>ge and is based<br />

on tri-sodium citrate and can be safely used <strong>in</strong> all catheters!<br />

Please f<strong>in</strong>d the different catheter lock solutions<br />

like Citra-lock and CitraFlow by Dir<strong>in</strong>co on<br />

www.citra-lock.com<br />

Dustri Verlag ...................................................Booth 1.P1<br />

Cl<strong>in</strong>ical Nephrology – Dustri Verlag<br />

For almost 40 years, Cl<strong>in</strong>ical Nephrology, a Dustri-<br />

Verlag publication, has been one <strong>of</strong> the lead<strong>in</strong>g journals<br />

<strong>in</strong> its field. Under the edit<strong>ors</strong>hip <strong>of</strong> H.H. Malluche<br />

(Lex<strong>in</strong>gton, KT, USA) – supported by 18 Section Edit<strong>ors</strong><br />

– the editorial quality has improved significantly<br />

due to a remarkable <strong>in</strong>crease <strong>of</strong> manuscript submissions.<br />

Also ask for our special fellowship program.<br />

The book program <strong>of</strong> Dustri-Verlag was extended by<br />

“Seyffart’s Directory <strong>of</strong> Drug Dosage <strong>in</strong> Kidney Disease”<br />

<strong>in</strong> 2011<br />

www.cl<strong>in</strong>nephrol.com - www.dustri.com<br />

DV Care ............................................................ Booth 1.29<br />

DV Care., a wholly owned subsidiary <strong>of</strong> a United States<br />

based FORTUNE 500 ® company that is a lead<strong>in</strong>g provider<br />

<strong>of</strong> kidney care <strong>in</strong> the United States, deliver<strong>in</strong>g dialysis<br />

services to patients with chronic kidney failure and end<br />

stage renal disease. As <strong>of</strong> December 31, 2011, the organization<br />

operated or provided adm<strong>in</strong>istrative services<br />

at 1,809 dialysis facilities <strong>in</strong> the United States, serv<strong>in</strong>g<br />

approximately 142,000 patients. The company also operated<br />

11 outpatient dialysis centers located <strong>in</strong> three countries<br />

outside the United States. In l<strong>in</strong>e with the overall<br />

corporate mission, DV Care strives to improve patients’<br />

quality <strong>of</strong> life by <strong>in</strong>novat<strong>in</strong>g cl<strong>in</strong>ical care, and by <strong>of</strong>fer<strong>in</strong>g<br />

<strong>in</strong>tegrated treatment plans, personalized care teams<br />

and convenient health-management services. The organization<br />

also supports numerous programs dedicated<br />

to creat<strong>in</strong>g positive, susta<strong>in</strong>able change <strong>in</strong> communities<br />

around the world. The company’s leadership development<br />

<strong>in</strong>itiatives and social responsibility efforts have<br />

been recognized by Fortune, Modern Healthcare, Newsweek<br />

and WorldBlu. For <strong>in</strong>quiries dial +310 536 2478 or<br />

w w w . e r a e d t a 2 0 1 2 . o r g<br />

403<br />

EXHIBITORS


EXHIBITORS<br />

404<br />

49 th <strong>ERA</strong>-<strong>EDTA</strong> CONGRESS<br />

E X H I B I T O R S<br />

send an email to global@davita.com.<br />

DWA ................................................................. Booth 2.81<br />

DWA - The Dialysis Water Specia<strong>list</strong>s<br />

DWA has specialised <strong>in</strong> <strong>in</strong>novative solutions for the<br />

supply <strong>of</strong> high purity water to dialysis centres - worldwide.<br />

DWA develops systems for production <strong>of</strong> ultrapure<br />

permeate and its distribution right to the dialysis<br />

mach<strong>in</strong>e. Our expertise <strong>in</strong> water treatment covers all<br />

aspects from the pre-treatment stages, through reverse<br />

osmosis, ultrafiltration and hot clean<strong>in</strong>g systems, right<br />

up to the supply connection through to the dialysis<br />

mach<strong>in</strong>e. In addition, DWA <strong>of</strong>fers systems for production<br />

and distribution <strong>of</strong> acid and bicarbonate concentrates.<br />

DWA is partner for dialysis centres - worldwide!<br />

www.dwa-onl<strong>in</strong>e.com<br />

E.D.P. La Traccia .......................................... Booth 1.G22<br />

Cooperativa Edp La Traccia is:<br />

- a Research Laboratory for the ICT and Robotic sect<strong>ors</strong>;<br />

- certified ISO 9001:2000 for the design, development,<br />

ma<strong>in</strong>tenance, assistance and sale <strong>of</strong> s<strong>of</strong>tware and<br />

hardware products; design<strong>in</strong>g and implementation<br />

<strong>of</strong> pr<strong>of</strong>essional tra<strong>in</strong><strong>in</strong>g projects;<br />

- certified ISO 27001 for specialized consultancy and<br />

expert technical assistance <strong>of</strong> s<strong>of</strong>tware and hardware<br />

products, management <strong>of</strong> LAN networks and<br />

<strong>in</strong>ternal <strong>in</strong>frastructures;<br />

- a recognized Tra<strong>in</strong><strong>in</strong>g Centre by the Basilicata Region.<br />

La Traccia, thanks to state-<strong>of</strong>-the-art technology and<br />

the large number <strong>of</strong> solutions <strong>in</strong> place with customers<br />

distributed all over Italy, is the Italian market leader<br />

for the supply <strong>of</strong>:<br />

- s<strong>of</strong>tware applications for Nephrology and Dialysis<br />

hospital wards (<strong>in</strong>stalled <strong>in</strong> over 210 Italian hospitals);<br />

- s<strong>of</strong>tware products for the Management <strong>of</strong> Organ<br />

Transplant Wait<strong>in</strong>g Lists (<strong>in</strong>stalled <strong>in</strong> 9 Italian Regions);<br />

- s<strong>of</strong>tware application to manage the Regional Dialysis<br />

and Organ Transplant Register (<strong>in</strong>stalled <strong>in</strong> 8 Italian<br />

Regions);<br />

- s<strong>of</strong>tware application for the management <strong>of</strong> “Register<br />

<strong>of</strong> Medical and Dental Surgeons (<strong>in</strong>stalled <strong>in</strong> 20<br />

Italian Prov<strong>in</strong>cial Orders);<br />

w w w . e r a e d t a 2 0 1 2 . o r g


MAY 24-27, 2012 PARIS, France<br />

E X H I B I T O R S<br />

The company has furthermore:<br />

- maturated significant experience <strong>in</strong> the computerization<br />

<strong>of</strong> Hospital Patient Records, with vertical <strong>in</strong>tegration<br />

for the various specializations;<br />

- carried out research projects: the most important<br />

<strong>of</strong> which was relative to Theme 7 <strong>of</strong> the National<br />

Research Project <strong>of</strong> Telemedic<strong>in</strong>e funded by the<br />

M.I.U.R. (Monitor<strong>in</strong>g <strong>of</strong> Dialysis and Per<strong>in</strong>atal Outpatients).<br />

www.latraccia.it<br />

EffeEmme ........................................................ Booth 2.44<br />

We have been produc<strong>in</strong>g bloodl<strong>in</strong>es and accessories<br />

for haemodialysis treatments for 30 years. Our company<br />

structure, always evolv<strong>in</strong>g, allows us to promptly<br />

react to the <strong>in</strong>creas<strong>in</strong>g requirements <strong>of</strong> the market. Our<br />

customers have confidence <strong>in</strong> us as a reliable partner<br />

with a track record <strong>of</strong> long last<strong>in</strong>g cooperation. On<br />

time delivery and service are our standard.<br />

www.effeemme.it<br />

EG Medical Systems ...................................... Booth 1.62<br />

EG-Medical Systems manufactures and supplies regionally<br />

a rich span <strong>of</strong> medical disposables and devices<br />

<strong>in</strong>clud<strong>in</strong>g Medical, Surgical & Dialysis disposables<br />

e.g. Blood L<strong>in</strong>es & Fistula Needles, Ur<strong>in</strong>e & Dra<strong>in</strong>age<br />

bags, Infusion & Transfusion sets, CVP, at top quality<br />

level s<strong>in</strong>ce year 2000. The company has been merited<br />

ISO 9001, ISO 13485, CE 0120 www.eggroup-eg.com<br />

Elsevier Masson ..............................................Booth 1.P4<br />

Elsevier Masson is the first French speak<strong>in</strong>g medical<br />

and paramedical publisher. Its three ma<strong>in</strong>s activities<br />

are the publish<strong>in</strong>g <strong>of</strong> books for <strong>in</strong>itial or cont<strong>in</strong>u<strong>in</strong>g<br />

education, <strong>of</strong> EMC treaties, and the publication<br />

<strong>of</strong> medical and paramedical journals. The university<br />

books, written by the best teachers, form all the pr<strong>of</strong>ession<br />

<strong>of</strong> health for two centuries. The books <strong>of</strong> cont<strong>in</strong>uous<br />

medical education, written by the best experts<br />

hospitalo-university and <strong>in</strong>tended for the pr<strong>of</strong>essionals<br />

<strong>of</strong> health, the general practitioner, the specia<strong>list</strong>s,<br />

the pharmacists, the dental surgeons, the veter<strong>in</strong>arians<br />

and <strong>in</strong> the all paramedical, <strong>in</strong>sure the permanent update<br />

<strong>of</strong> their practical knowledge. www.elsevier.com<br />

w w w . e r a e d t a 2 0 1 2 . o r g<br />

405<br />

EXHIBITORS


EXHIBITORS<br />

406<br />

49 th <strong>ERA</strong>-<strong>EDTA</strong> CONGRESS<br />

E X H I B I T O R S<br />

Emodial ............................................................ Booth 2.42<br />

Emodial Srl was established <strong>in</strong> 1982 <strong>in</strong> Ferrara, Italy,<br />

and s<strong>in</strong>ce that time has been operat<strong>in</strong>g <strong>in</strong> the field <strong>of</strong><br />

haemodialysis provid<strong>in</strong>g a complete range <strong>of</strong> products<br />

for dress<strong>in</strong>gs and becom<strong>in</strong>g one the lead<strong>in</strong>g companies<br />

<strong>in</strong> the field. Our products have been designed on the basis<br />

<strong>of</strong> the suggestions and co-operation <strong>of</strong>fered by various<br />

Dialysis Centres <strong>of</strong> relevant Care Units, which felt<br />

the need for new products suitable for the medications<br />

and absorption <strong>of</strong> wound exudates, to be used as an alternative<br />

to the traditional cotton or non-woven pads.<br />

Our ma<strong>in</strong> products can be referable to the follow<strong>in</strong>g<br />

typologies:<br />

-pads, plasters and bandages for fistula;<br />

-start-stop kits for haemodialysis, catheterism and<br />

peritoneal dialysis<br />

-devices for the disposal <strong>of</strong> used fistula needles;<br />

We have also recently developed a new range <strong>of</strong> patented<br />

products based on silver which helps to control<br />

the risk <strong>of</strong> <strong>in</strong>fections <strong>of</strong> the vascular access.<br />

www.emodial.it<br />

<strong>ERA</strong>-<strong>EDTA</strong> 2013 <strong>Congress</strong> Istanbul ........ Booth 1.G14<br />

The <strong>ERA</strong>-<strong>EDTA</strong> congress that will be held <strong>in</strong> Istanbul<br />

<strong>in</strong> 2013 (May 18-21) will be the 50 th annual congress <strong>of</strong><br />

this association. In order to mark this important anniversary<br />

the scientific programme will be richer than<br />

usual, with more pathways and more courses. The<br />

venue for this event will be the recently built Istanbul<br />

<strong>Congress</strong> Center, completed <strong>in</strong> September 2009 and<br />

situated <strong>in</strong> Harbiye, on a hilltop overlook<strong>in</strong>g the Bosphorus.<br />

Information will be available at the booth and<br />

<strong>in</strong> the website www.era-edta2013.org<br />

w w w . e r a e d t a 2 0 1 2 . o r g


MAY 24-27, 2012 PARIS, France<br />

E X H I B I T O R S<br />

Etropal .............................................................. Booth 1.11<br />

Etropal is a company with over thirty years <strong>of</strong> experience<br />

<strong>in</strong> research, development and manufactur<strong>in</strong>g <strong>of</strong><br />

medical devices for s<strong>in</strong>gle use, meet<strong>in</strong>g all the requirements<br />

<strong>of</strong> a contemporary medic<strong>in</strong>e <strong>in</strong> this field. The<br />

company <strong>of</strong>fers an extensive product l<strong>in</strong>e that spans<br />

medical devices for haemodialysis-dialysers, blood<br />

l<strong>in</strong>es, fistula needles and other medical devices. The<br />

company operates a fully <strong>in</strong>tegrated ‘quality assurance<br />

system’ accord<strong>in</strong>g to ISO 9001 and ISO 13485.<br />

www.etropal.eu<br />

M E D I C A L E Q U I P M E N T<br />

Eurocl<strong>in</strong>ic ........................................................ Booth 1.G5<br />

Eurocl<strong>in</strong>ic SpA is a lead<strong>in</strong>g manufactur<strong>in</strong>g company<br />

specialized <strong>in</strong> the production <strong>of</strong> high-tech Medical<br />

Equipments presently distributed and appreciated <strong>in</strong><br />

more than 27 foreign countries ma<strong>in</strong>ly for the elegant<br />

design and the technical reliability. The cont<strong>in</strong>uous<br />

Research and Development activity is focused on<br />

state-<strong>of</strong>-art l<strong>in</strong>es <strong>of</strong> Units and Chairs for ENT, Podiatry,<br />

Gynaecology, Diagnostic & Imag<strong>in</strong>g fields. A new<br />

product for Dialysis/Oncology has been developed <strong>in</strong><br />

the last year thanks to a highly experienced team <strong>of</strong><br />

eng<strong>in</strong>eers. www.eurocl<strong>in</strong>ic.it<br />

FedAirg ............................................................ Booth 1.G9<br />

Federg is an <strong>in</strong>itiative aimed at establish<strong>in</strong>g a European<br />

federation <strong>of</strong> patients with renal genetic diseases<br />

(RGD). Federg will gather European associations devoted<br />

to RGD, thus provid<strong>in</strong>g enough voice and room<br />

to the smallest ones and given them more empowerment<br />

with<strong>in</strong> the European community: better <strong>in</strong>form,<br />

help and advocate, support research, better represent<br />

patients and foster the development <strong>of</strong> national associations.<br />

AIRG-France, a French association, focuss<strong>in</strong>g<br />

on Renal Genetic Diseases (RGD), has taken the <strong>in</strong>itiative<br />

<strong>of</strong> FEDERG and was promptly jo<strong>in</strong>ed by other<br />

AIRGs <strong>in</strong> Europe (Belgium, Switzerland and Spa<strong>in</strong>)<br />

and other RGD associations. It has received the support<br />

<strong>of</strong> <strong>ERA</strong>-<strong>EDTA</strong>, ESPN and Eurordis. The project<br />

will be developed <strong>in</strong> 2012, <strong>in</strong>formation can be found<br />

on the follow<strong>in</strong>g sites:<br />

www.federg2012.wordpress.com - www.airg-france.fr<br />

w w w . e r a e d t a 2 0 1 2 . o r g<br />

407<br />

EXHIBITORS


EXHIBITORS<br />

408<br />

49 th <strong>ERA</strong>-<strong>EDTA</strong> CONGRESS<br />

E X H I B I T O R S<br />

French Society <strong>of</strong> Dialysis ......................... Booth 1.G11<br />

The Société de Francophone de Dialyse (SFD) is a<br />

French speak<strong>in</strong>g association <strong>of</strong> nephrologists founded<br />

<strong>in</strong> 1993, currently hav<strong>in</strong>g about 800 members throughout<br />

the French speak<strong>in</strong>g countries. The French speak<strong>in</strong>g<br />

Society <strong>of</strong> Dialysis aims to improve formation and<br />

collaborative work <strong>in</strong> dialysis through an annual Jo<strong>in</strong>t<br />

Meet<strong>in</strong>g with the Société de Néphrologie, and by organiz<strong>in</strong>g<br />

annually two or more specific CME courses <strong>in</strong><br />

collaboration with the Moroccan Society <strong>of</strong> Nephrology<br />

and the Tunisian Society <strong>of</strong> Nephrology. SFD contributes<br />

further to research on dialysis and end stage<br />

renal disease by fund<strong>in</strong>g cl<strong>in</strong>ical and fundamental research<br />

programmes. Publication media are the journal<br />

«Néphrologie & Thérapeutique», the e-learn<strong>in</strong>g website<br />

www.re<strong>in</strong>-eform.org and the society own website<br />

www.sfdial.org. Please visit the booth to learn more<br />

on SFD and jo<strong>in</strong> us.<br />

French Society <strong>of</strong> Nephrology .................... Booth 1.G8<br />

The Société de Néphrologie (SN) is a French speak<strong>in</strong>g<br />

association <strong>of</strong> nephrologists founded <strong>in</strong> 1961, currently<br />

hav<strong>in</strong>g about 1500 members. Its publication is<br />

Néphrologie & Thérapeutique. SN contributes to the<br />

dissem<strong>in</strong>ation <strong>of</strong> knowledge by its annual Jo<strong>in</strong>t Meet<strong>in</strong>g<br />

with the Société Francophone de Dialyse, and by<br />

organiz<strong>in</strong>g annually a specific CME course. SN contributes<br />

to research <strong>in</strong> nephrology directly by fund<strong>in</strong>g<br />

research projects both for laboratories and <strong>in</strong>dividual<br />

researchers as post-doctoral tra<strong>in</strong><strong>in</strong>gs. Visit the booth<br />

to learn about the next annual Jo<strong>in</strong>t Meet<strong>in</strong>g: Geneva,<br />

October 2-5, 2012. More <strong>in</strong>formation at:<br />

www.soc-nephrologie.org<br />

Fresenius Kabi ................................................ Booth 2.68<br />

Fresenius Kabi is dedicated to the therapy and care <strong>of</strong><br />

critically and chronically ill patients <strong>in</strong>side and outside<br />

the hospital by provid<strong>in</strong>g <strong>in</strong>travenously adm<strong>in</strong>istered<br />

drugs, <strong>in</strong>fusion therapies, cl<strong>in</strong>ical nutrition and related<br />

medical devices. The company applies its long-stand<strong>in</strong>g<br />

expertise <strong>in</strong> pharmaceuticals and medical devices<br />

to support cl<strong>in</strong>ical staff and care pr<strong>of</strong>essionals <strong>in</strong> the<br />

best therapy <strong>of</strong> patients. For more <strong>in</strong>formation about<br />

Fresenius Kabi, visit the company’s Web site at<br />

www.fresenius-kabi.com.<br />

w w w . e r a e d t a 2 0 1 2 . o r g


MAY 24-27, 2012 PARIS, France<br />

E X H I B I T O R S<br />

Fresenius Medical Care ................................. Booth 2.68<br />

Fresenius Medical Care is the world’s largest <strong>in</strong>tegrated<br />

provider <strong>of</strong> products and services for <strong>in</strong>dividuals<br />

undergo<strong>in</strong>g dialysis because <strong>of</strong> chronic kidney failure,<br />

a condition that affects more than 2.1 million <strong>in</strong>dividuals<br />

worldwide. Through its network <strong>of</strong> more than<br />

2,890 dialysis cl<strong>in</strong>ics <strong>in</strong> North America, Europe, Lat<strong>in</strong><br />

America, Asia-Pacific and Africa, Fresenius Medical<br />

Care provides dialysis treatment to more than 233,100<br />

patients around the globe. Fresenius Medical Care is<br />

also the world’s lead<strong>in</strong>g provider <strong>of</strong> dialysis products<br />

such as hemodialysis mach<strong>in</strong>es, dialyzers and related<br />

disposable products. With the new bus<strong>in</strong>ess unit Renal<br />

Pharma Fresenius Medical Care is now complement<strong>in</strong>g<br />

its lead<strong>in</strong>g dialysis technologies, products and<br />

services with renal pharmaceuticals. We will cont<strong>in</strong>uously<br />

build up and provide a comprehensive range <strong>of</strong><br />

drugs and drive their <strong>in</strong>tegration <strong>in</strong>to <strong>in</strong>novative treatment<br />

platforms to achieve improved therapeutic outcomes<br />

<strong>in</strong> dialysis patients. www.fmc-ag.de<br />

Gambro ............................................................ Booth 2.46<br />

Gambro has been pioneer<strong>in</strong>g solutions for patients <strong>in</strong><br />

Chronic and Acute Therapies for more than 47 years.<br />

With you and your patients as our <strong>in</strong>spiration, we are<br />

constantly seek<strong>in</strong>g ways to advance the science <strong>of</strong> dialysis.<br />

The result is <strong>in</strong>novative products & therapies<br />

that will support your success. Gambro - Your home <strong>of</strong><br />

INNOVATION - You <strong>in</strong>spire, We <strong>in</strong>novate.<br />

www.gambro.com<br />

Gardhen Bilance ...........................................Booth 1.98C<br />

Gardhen bilance is a company presents <strong>in</strong> most parts<br />

<strong>of</strong> the world thanks to its exclusive distribut<strong>ors</strong> and to<br />

high quality <strong>of</strong> the products. The beds and chairs with<br />

or without scales are presents <strong>in</strong> all privates dialysis<br />

centers and dialysis hospital departments. Gardhen bilance<br />

manufactures medical devices and weigh<strong>in</strong>g systems<br />

<strong>in</strong> conformity to ISO 9001:2008, ISO 13485:2003,<br />

93/42/CEE. Design, comfort, robust construction is<br />

our mission www.gardhenbilance.it<br />

w w w . e r a e d t a 2 0 1 2 . o r g<br />

409<br />

EXHIBITORS


EXHIBITORS<br />

410<br />

49 th <strong>ERA</strong>-<strong>EDTA</strong> CONGRESS<br />

E X H I B I T O R S<br />

HemoSapiens ............................................... Booth 1.G24<br />

Hemo Sapiens ® Inc is a high-tech medical company<br />

specialized <strong>in</strong> the development <strong>of</strong> non-<strong>in</strong>vasive medical<br />

devices designed for the real-time assessment,<br />

monitor<strong>in</strong>g and management <strong>of</strong> complete hemodynamics.<br />

Hemo Sapiens ® ® flagship product is Hotman ®<br />

- a PC-based system for automatic, non<strong>in</strong>vasive and<br />

hands-free acquisition <strong>of</strong> a patient’s blood flow and<br />

left-ventricular parameters us<strong>in</strong>g Company’s proprietary<br />

very-low current TEB (Thoracic Electrical Bioimpedance)<br />

provid<strong>in</strong>g the unique Integrated Hemodynamic<br />

Management solution.<br />

www.hemosapiens.net<br />

Herco Wassertechnik ..................................... Booth 2.64<br />

Herco developed and <strong>of</strong>fers complete water treatment<br />

solutions for dialysis applications. Products are: Water<br />

s<strong>of</strong>teners, filters, reverse osmosis, r<strong>in</strong>g ma<strong>in</strong>, bed<br />

head media panels, central concentrate distribution.<br />

Reverse osmosis units for haemodialysis purposes accord<strong>in</strong>g<br />

to MDD, TÜV approved. www.herco-wt.de<br />

Hospira UK ...................................................... Booth 2.83<br />

Hospira is a global speciality pharmaceutical and<br />

medication delivery company dedicated to Advanc<strong>in</strong>g<br />

Wellness. As a world expert <strong>in</strong> speciality generic<br />

<strong>in</strong>jectable pharmaceuticals, Hospira <strong>of</strong>fers one <strong>of</strong> the<br />

broadest portfolios <strong>of</strong> generic acute-care and oncology<br />

<strong>in</strong>jectables, as well as <strong>in</strong>tegrated <strong>in</strong>fusion therapy<br />

and medication management solutions. Through its<br />

products, Hospira helps improve the safety, cost and<br />

productivity <strong>of</strong> patient care. The company is headquartered<br />

<strong>in</strong> Lake Forest, Ill<strong>in</strong>ois, United States and<br />

has more than 14,000 employees. The head <strong>of</strong>fice for<br />

Hospira <strong>in</strong> Europe, Middle East and Africa is <strong>in</strong> Royal<br />

Leam<strong>in</strong>gton Spa, UK. Learn more about Hospira at<br />

www.hospira.com.<br />

w w w . e r a e d t a 2 0 1 2 . o r g


MAY 24-27, 2012 PARIS, France<br />

E X H I B I T O R S<br />

IFKF - International Federation<br />

<strong>of</strong> Kidney Foundation .................................. Booth 1.G4<br />

Improv<strong>in</strong>g Kidney Health Worldwide<br />

Our Long Term Commitment:<br />

Improvement <strong>in</strong> prevention, quality <strong>of</strong> life and health<br />

for all people with or at risk <strong>of</strong> kidney disease, regardless<br />

<strong>of</strong> race, color, creed, gender, sexual orientation or<br />

social class.<br />

Our Mission:<br />

To foster creation, growth, and <strong>in</strong>ternational collaboration<br />

between local kidney foundations and to enable<br />

and help empower member organizations to atta<strong>in</strong> our<br />

goals. To represent at the <strong>in</strong>ternational level the needs<br />

<strong>of</strong> people with, or at risk <strong>of</strong> kidney disease. Our worldwide<br />

community <strong>of</strong> kidney foundations constitutes a<br />

unique and potent force to br<strong>in</strong>g a global <strong>in</strong>strument<br />

for the prevention, detection and treatment <strong>of</strong> kidney<br />

disease.<br />

Our Tools:<br />

Annual meet<strong>in</strong>g, regional meet<strong>in</strong>gs, Kidney Foundations<br />

Partnership Program KFPP, educational programs<br />

and sem<strong>in</strong>ars for health care workers on nutrition<br />

and other topics. SeeKD ® program for detection<br />

and prevention <strong>of</strong> CKD. Joel D Kopple Award for<br />

outstand<strong>in</strong>g performance, IFKF Innovation Challenge<br />

for <strong>in</strong>novative ideas for compliance with medic<strong>in</strong>e use.<br />

World Kidney Day, <strong>in</strong> cooperation with ISN.<br />

www.ikfk.net<br />

w w w . e r a e d t a 2 0 1 2 . o r g<br />

411<br />

EXHIBITORS


EXHIBITORS<br />

412<br />

49 th <strong>ERA</strong>-<strong>EDTA</strong> CONGRESS<br />

E X H I B I T O R S<br />

Immundiagnostik ....................................... Booth 1.G19<br />

Clos<strong>in</strong>g the Gaps <strong>in</strong> Laboratory Diagnostics<br />

Immundiagnostik AG, founded <strong>in</strong> 1986, is a globally<br />

operat<strong>in</strong>g diagnostics company represented <strong>in</strong> over 30<br />

countries. We focus on the development and production<br />

<strong>of</strong> <strong>in</strong>novative immunoassays (ELISA, EIA) and<br />

other analytical detection methods (e.g. HPLC, LC-<br />

MS/MS and PCR) for medical rout<strong>in</strong>e and research.<br />

Our mission is to provide effective tools for prevention,<br />

differential diagnosis and therapy monitor<strong>in</strong>g <strong>in</strong><br />

the areas <strong>of</strong> gastroenterology, cardiovascular diseases,<br />

disorders <strong>of</strong> the skeletal system and oxidative stress.<br />

The product portfolio is completed by a broad range<br />

<strong>of</strong> antibodies and antigens. Our bus<strong>in</strong>ess relations <strong>in</strong>clude<br />

contract analyses for diagnostic laboratories and<br />

academic research <strong>in</strong>stitutions, esp. <strong>in</strong> context with<br />

cl<strong>in</strong>ical trials. Multiple cooperations with the pharmaceutical<br />

<strong>in</strong>dustry and a tight network with scientific<br />

organisations are the basis for a successful product<br />

development. Secur<strong>in</strong>g progress: Our comprehensive<br />

range <strong>of</strong> products is cont<strong>in</strong>uously refuelled by a rich<br />

pipel<strong>in</strong>e <strong>of</strong> proprietary developments. With a headcount<br />

<strong>of</strong> more than 60 employees, Immundiagnostik’s<br />

headquarter is located <strong>in</strong> Bensheim, south-western<br />

Germany. www.immundiagnostik.com<br />

Infomed ............................................................ Booth 1.45<br />

With 20 years <strong>of</strong> experiences around the world, Infomed<br />

has comforted its leadership as a provider <strong>of</strong><br />

extracorporeal blood purification devices <strong>of</strong>fer<strong>in</strong>g<br />

complete solutions with many advanced medical<br />

treatments such as: Cont<strong>in</strong>uous hem<strong>of</strong>iltration and hemodiafiltration,<br />

plasma exchange, cascade filtration,<br />

double filtration plasmapheresis (DFPP), blood and<br />

plasma perfusion and CPFA (Coupled Plasma Filtration<br />

Adsorption). Infomed provides a complete range<br />

<strong>of</strong> mach<strong>in</strong>es and all associated disposables such as<br />

pre-assembled kits, filters and adsorption cartridges.<br />

www.<strong>in</strong>fomed.biz<br />

w w w . e r a e d t a 2 0 1 2 . o r g


MAY 24-27, 2012 PARIS, France<br />

E X H I B I T O R S<br />

Innovative Blood Purification...................... Booth 1.50<br />

We are an <strong>in</strong>tegrated provider <strong>of</strong> hemodialysis medical<br />

disposables products, such as Dialyzers, Bloodl<strong>in</strong>e<br />

Sets & AV Fistula Needle Sets and Dialysate Solution,<br />

for <strong>in</strong>dividuals undergo<strong>in</strong>g dialysis due to chronic<br />

kidney failure. We manufacture and distribute our<br />

hemodialysis medical disposables to dialysis cl<strong>in</strong>ics<br />

all over Eastern Europe, Middle East and Asia Pacific.<br />

Through our jo<strong>in</strong>tly-owned German subsidiary, International<br />

Dialysers Technologies GmbH (“IDT”) that<br />

own and manage a dialyzer assembly plant <strong>in</strong> Germany,<br />

we were able to develop our Dialyzer under our<br />

own brand name “Innovative”, we also manufactured<br />

our products via our OEM Partners. All our products<br />

are certified with CE and ISO 13485.<br />

www.<strong>in</strong>novative-bp.com<br />

Intermedt Mediz<strong>in</strong> & Technik .................... Booth 1.97<br />

Intermedt was founded <strong>in</strong> 1997 and is a specia<strong>list</strong> for<br />

dialysis concentrate production systems.<br />

The fully automatic dry concentrate system ECOMix<br />

<strong>in</strong> comb<strong>in</strong>ation with ECOCart allows the production<br />

<strong>of</strong> concentrate <strong>in</strong> your own dialysis center. We<br />

don’t transport any Water only the dry salts <strong>in</strong> large<br />

cartridges. The “ECOCart” is a reusable cartridge and<br />

conta<strong>in</strong>s all raw materials <strong>in</strong> dry form for the production<br />

<strong>of</strong> 750l acid concentrate. www.<strong>in</strong>termedt.de<br />

ISN International Society <strong>of</strong> Nephrology Booth 1.G3<br />

The International Society <strong>of</strong> Nephrology (ISN) is a<br />

global not-for-pr<strong>of</strong>it society dedicated to its philanthropic<br />

mission <strong>of</strong> advanc<strong>in</strong>g the diagnosis, treatment,<br />

and prevention <strong>of</strong> kidney diseases <strong>in</strong> the develop<strong>in</strong>g<br />

and developed world. S<strong>in</strong>ce its foundation <strong>in</strong> 1960,<br />

ISN has pursued the worldwide advancement <strong>of</strong> education,<br />

science and patient care <strong>in</strong> nephrology. The<br />

Society represents a wide <strong>in</strong>ternational network and<br />

provides an efficient platform for timely scientific exchange,<br />

debate and dissem<strong>in</strong>ation between healthcare<br />

pr<strong>of</strong>essionals around the world. ISN has over 9,000<br />

pr<strong>of</strong>essional members from more than 126 countries.<br />

In addition, ISN closely collaborates with over 70 national<br />

and regional nephrology societies around the<br />

world, represent<strong>in</strong>g about 20,000 pr<strong>of</strong>essionals.<br />

www.theisn.org<br />

w w w . e r a e d t a 2 0 1 2 . o r g<br />

413<br />

EXHIBITORS


EXHIBITORS<br />

414<br />

49 th <strong>ERA</strong>-<strong>EDTA</strong> CONGRESS<br />

E X H I B I T O R S<br />

Janssen .............................................................. Booth 2.37<br />

Janssen Pharmaceutical Companies <strong>of</strong> Johnson &<br />

Johnson are dedicated to address<strong>in</strong>g and solv<strong>in</strong>g the<br />

most important unmet medical needs <strong>of</strong> our time, <strong>in</strong>clud<strong>in</strong>g<br />

oncology (e.g. multiple myeloma and prostate<br />

cancer), immunology (e.g. psoriasis), neuroscience<br />

(e.g. schizophrenia, dementia and pa<strong>in</strong>), <strong>in</strong>fectious<br />

disease (e.g. HIV/AIDS, Hepatitis C and tuberculosis),<br />

and cardiovascular and metabolic diseases (e.g.<br />

diabetes). Driven by our commitment to patients, we<br />

develop susta<strong>in</strong>able, <strong>in</strong>tegrated healthcare solutions<br />

by work<strong>in</strong>g side-by-side with healthcare stakeholders,<br />

based on partnerships <strong>of</strong> trust and transparency. More<br />

<strong>in</strong>formation can be found at www.janssen-emea.com<br />

JiHua Medical Apparatus and Instruments .Booth 1.G17<br />

Jihua Medical Apparatus and Instruments Co.,LTD<br />

GuangZhou (Jihua Company), established <strong>in</strong> 2000. We<br />

are specialized to research, produce and sell hemodialysis<br />

equipment and some relative blood purification<br />

devices such as electric dialysis chair, RO water<br />

unit, dialyzer reprocess<strong>in</strong>g mach<strong>in</strong>e, hemoperfusion<br />

mach<strong>in</strong>e, blood pump, dialysate powder stirr<strong>in</strong>g mach<strong>in</strong>e<br />

ect. Our dialysis equipments have ga<strong>in</strong>ed the CE<br />

mark and company are certified with ISO 9001&ISO<br />

13485 <strong>in</strong> 2007. So far, Jihua products are sell<strong>in</strong>g <strong>in</strong> the<br />

whole prov<strong>in</strong>ces <strong>in</strong> ch<strong>in</strong>a and successfully exported<br />

to more than 60 countries <strong>in</strong> Asia, South America, Europe<br />

and Africa countries. Our vision is to contribute<br />

to the growth <strong>of</strong> <strong>in</strong>ternational blood purification career<br />

and to be the leadership on nephrology with the most<br />

pr<strong>of</strong>essional and susta<strong>in</strong>able development ability and<br />

outstand<strong>in</strong>g corporate culture. www.ji-hua.com<br />

Jol<strong>in</strong>e ................................................................. Booth 1.34<br />

Jol<strong>in</strong>e GmbH & Co. KG is an <strong>in</strong>ternationally operat<strong>in</strong>g<br />

company <strong>in</strong> southern Germany with a strong focus<br />

on quality standards and <strong>in</strong>novative, medical technologies.<br />

S<strong>in</strong>ce our foundation <strong>in</strong> 1999 it has been our<br />

<strong>in</strong>tent to develop and produce high-quality products<br />

<strong>in</strong> the field <strong>of</strong> Vascular Access. All our FlowFamily-<br />

Products are CE marked and exclusively “Made <strong>in</strong><br />

Germany”. www.jol<strong>in</strong>e.net<br />

w w w . e r a e d t a 2 0 1 2 . o r g


MAY 24-27, 2012 PARIS, France<br />

E X H I B I T O R S<br />

Karger ...............................................................Booth 1.P6<br />

S. Karger Medical Publishers is a publish<strong>in</strong>g house<br />

whose publications <strong>in</strong> the field <strong>of</strong> nephrology <strong>in</strong>clude<br />

6 scientific journals, e.g. ‘Nephron’, and the renowned<br />

book series ‘Contributions to Nephrology’. New releases<br />

presented <strong>in</strong>clude the titles Hepatitis C <strong>in</strong> Renal<br />

Disease, Hemodialysis and Transplantation’, ‘On-L<strong>in</strong>e<br />

Hemodiafiltration: The Journey and the Vision’ and<br />

‘Controversies <strong>in</strong> Acute Kidney Injury’. Publications<br />

are accessible onl<strong>in</strong>e, with full-text search <strong>of</strong> articles,<br />

pay-per-view options and many other services. Founded<br />

122 years ago, this Swiss-based family-owned publish<strong>in</strong>g<br />

house comb<strong>in</strong>es highly sophisticated production<br />

technology with customized services for its auth<strong>ors</strong>,<br />

edit<strong>ors</strong> and readers.<br />

www.karger.com/nephrology<br />

Kawasumi ........................................................ Booth 2.05<br />

S<strong>in</strong>ce 1957, Kawasumi Laboratories has been provid<strong>in</strong>g<br />

nephrologists worldwide dialyzers, blood tub<strong>in</strong>g<br />

l<strong>in</strong>es, and AV fistula sets. We are renowned for our<br />

consistently high quality. Kawasumi is a lead<strong>in</strong>g supplier<br />

<strong>of</strong> advanced dialyzers. The RENAK PS dialyzer<br />

will delight you with its high performance. Blood<br />

tub<strong>in</strong>g l<strong>in</strong>es and AV fistula sets are among the best<br />

known and most trusted <strong>in</strong> the world. Kawasumi also<br />

provides a wide variety <strong>of</strong> therapeutic plasmapheresis<br />

products. Visit the Kawasumi booth and see how we<br />

can help you provide excellent therapy!<br />

www.kawasumi.jp<br />

Kimal ................................................................ Booth 1.01<br />

w w w . e r a e d t a 2 0 1 2 . o r g<br />

415<br />

EXHIBITORS


EXHIBITORS<br />

416<br />

49 th <strong>ERA</strong>-<strong>EDTA</strong> CONGRESS<br />

E X H I B I T O R S<br />

Labor Limbach ............................................. Booth 1.G20<br />

Limbach Laboratory is the market leader <strong>in</strong> medical<br />

laboratory test<strong>in</strong>g <strong>in</strong> Germany as well as the largest<br />

provider <strong>of</strong> diagnostic services to nephrology<br />

departments, dialysis units and nephrologists <strong>in</strong> private<br />

practices. It was founded 1979 <strong>in</strong> Heidelberg by<br />

Dr.med. Hans-Jakob Limbach. A central focus <strong>of</strong> its<br />

activity was the determ<strong>in</strong>ation <strong>of</strong> parathyroid hormone<br />

and other special hormone test<strong>in</strong>g. Today, Limbach<br />

Laboratories Group covers all diagnostic fields <strong>of</strong><br />

laboratory medic<strong>in</strong>e with<strong>in</strong> 29 affiliated laboratories<br />

countrywide. Furthermore, it has built up a network<br />

<strong>of</strong> laboratory services throughout Europe. Last but not<br />

least, Limbach Laboratory has an active R&D program<br />

<strong>in</strong> the field <strong>of</strong> test development, particularly for markers<br />

<strong>of</strong> bone metabolism. www.labor-limbach.de<br />

Lauer ................................................................. Booth 2.12<br />

LMW/Aquaboss ® stands for <strong>in</strong>novation, quality and<br />

cost efficiency. S<strong>in</strong>ce 1989 Lauer is develop<strong>in</strong>g, manufactur<strong>in</strong>g<br />

and market<strong>in</strong>g RO systems, accessory equipment<br />

for dead space free supply <strong>of</strong> purified water and<br />

other liquid media used <strong>in</strong> dialysis. Dur<strong>in</strong>g the years<br />

Lauer has <strong>in</strong>troduced several patented technologies<br />

<strong>in</strong>renal market, e.g. impulse backwash<strong>in</strong>g and secondary<br />

r<strong>in</strong>g ma<strong>in</strong>s.<br />

www.aquaboss.com<br />

Likamed ........................................................... Booth 2.66<br />

We are an expert for therapy and treatment chairs<br />

and beds <strong>in</strong> the medical field and we are more than 30<br />

years successful <strong>in</strong> the market. Our long last<strong>in</strong>g experience<br />

und strict quality check, guarantee that the label<br />

“Made by Likamed” stands always for highest quality.<br />

Our products and our company are certificated for<br />

DIN EN ISO 13485. www.likamed.de<br />

w w w . e r a e d t a 2 0 1 2 . o r g


MAY 24-27, 2012 PARIS, France<br />

E X H I B I T O R S<br />

Medcomp ......................................................... Booth 1.71<br />

Medcomp, well known for its wide range <strong>of</strong> cuffed<br />

and uncuffed venous access catheters will be <strong>of</strong>fer<strong>in</strong>g<br />

new <strong>in</strong>formation on:<br />

1. Videos on new dialysis catheter implantation technique<br />

2. Catheter Lock<strong>in</strong>g Solutions<br />

3. Long Term Dialysis Catheters<br />

4. Acute Access Blood Purification Catheters<br />

www.medcompnet.com<br />

Medica Italia ................................................. Booth 1.100<br />

Mdica S.p.A. is located <strong>in</strong>side the biomedical district <strong>of</strong><br />

Mirandola near Modena Italy. Medica was established<br />

<strong>in</strong> 1985, and s<strong>in</strong>ce then it has been operat<strong>in</strong>g <strong>in</strong> the<br />

manufactur<strong>in</strong>g and sales <strong>of</strong> medical devices specifically<br />

<strong>in</strong> the field <strong>of</strong> blood purification and recently also<br />

<strong>in</strong> water purification, provid<strong>in</strong>g an extensive range <strong>of</strong><br />

products. Blood l<strong>in</strong>es, Dialysers, Electro medical mach<strong>in</strong>es<br />

and associated disposables and Infusion disposables<br />

are at the core <strong>of</strong> Medica manufactur<strong>in</strong>g. S<strong>in</strong>ce<br />

the early 90’s Medica cont<strong>in</strong>ues to work on develop<strong>in</strong>g<br />

and manufactur<strong>in</strong>g <strong>of</strong> hollow fiber membranes for<br />

both medical and water purification applications. The<br />

development and manufactur<strong>in</strong>g <strong>of</strong> these technologies<br />

is primarily <strong>in</strong> house. www.medica.it<br />

Medikit ............................................................. Booth 1.35<br />

Medikit is a lead<strong>in</strong>g manufacturer <strong>of</strong> vascular access<br />

medical devices based <strong>in</strong> Tokyo, Japan. Supercath<br />

brand hemodialysis fistula catheter, upgrade replacement<br />

<strong>of</strong> steel fistula needle, can reduce risk <strong>of</strong> damage<br />

with cannulation on AV fistulas and AV Grafts. Catheters<br />

with safety mechanism prevent<strong>in</strong>g accidental<br />

needle-stick <strong>in</strong>juries are also available. Come and visit<br />

us at stand 1.35. www.medikit.co.jp<br />

w w w . e r a e d t a 2 0 1 2 . o r g<br />

417<br />

EXHIBITORS


EXHIBITORS<br />

418<br />

49 th <strong>ERA</strong>-<strong>EDTA</strong> CONGRESS<br />

E X H I B I T O R S<br />

Meditechlab & Suisse Med Technologies .... Booth 1.91<br />

Suisse Med Technologies is a market leader <strong>in</strong> provid<strong>in</strong>g<br />

synthetic hollow fiber sp<strong>in</strong>n<strong>in</strong>g l<strong>in</strong>es and dialyser<br />

assembly l<strong>in</strong>es. Our technology is designed to deliver<br />

optimal cost <strong>of</strong> goods while ensur<strong>in</strong>g worldwide quality<br />

standards. We support our customers achieve their<br />

f<strong>in</strong>ancial goals by <strong>of</strong>fer<strong>in</strong>g a wide range <strong>of</strong> additional<br />

services such as go-to-market strategies, regulatory<br />

compliance, ISO-10993 compliant devices and qualified<br />

raw materials. Our subsidiary, Meditechlab, is a<br />

supplier <strong>of</strong> quality dialysis products that meet all <strong>in</strong>ternational<br />

norms: ISO 9001 v-2000, ISO 13485 v-2003<br />

and the European Medical Device Directive 93/42/<br />

EEC (CE-mark).<br />

www.meditechlab.com www.SuisseMT.com<br />

MediTheque Bookshop ................................Booth 1.P5<br />

Medvision ...................................................... Booth 1.115<br />

As an <strong>in</strong>ternational developer <strong>of</strong> pr<strong>of</strong>essional medical<br />

<strong>in</strong>formation systems, we are provid<strong>in</strong>g efficient and<br />

economical solutions for the treatment and care <strong>of</strong> sick<br />

people for over twenty years now. Our medical <strong>in</strong>formation<br />

systems are used <strong>in</strong> many doctor’s practices,<br />

outpatient cl<strong>in</strong>ics, hospitals, dialysis units, and medical<br />

care centres. Especially <strong>in</strong> the field <strong>of</strong> dialysis, we<br />

have made a name for ourselves with a market share<br />

<strong>of</strong> well over 60 % <strong>in</strong> Germany and a large number <strong>of</strong><br />

customers <strong>in</strong> Europe and Asia. Our <strong>in</strong>ternational OEM<br />

cooperation partners are the world leaders <strong>in</strong> dialysis.<br />

www.medvision.de<br />

MedXL ........................................................... Booth 1.G10<br />

MedXL designs and manufactures quality healthcare<br />

products s<strong>in</strong>ce 1992 and is a leader <strong>in</strong> sett<strong>in</strong>g the standards<br />

for safe, secure and efficacious prefilled syr<strong>in</strong>ge<br />

products. Our prefilled CitraFlow syr<strong>in</strong>ges conta<strong>in</strong><strong>in</strong>g<br />

4% sodium citrate are currently used <strong>in</strong> many<br />

countries as an alternative to hepar<strong>in</strong> for lock<strong>in</strong>g catheters.<br />

CitraFlow is a natural way to safely and effectively<br />

lock <strong>in</strong>dwell<strong>in</strong>g catheters. www.medxl.com<br />

w w w . e r a e d t a 2 0 1 2 . o r g


MAY 24-27, 2012 PARIS, France<br />

E X H I B I T O R S<br />

Membrana........................................................ Booth 2.20<br />

Membrana is the largest <strong>in</strong>dependent membrane producer<br />

worldwide. Membrana is part <strong>of</strong> Polypore International<br />

Inc., a global high technology company<br />

specializ<strong>in</strong>g <strong>in</strong> microporous membranes. Membrana<br />

<strong>of</strong>fers a wide range <strong>of</strong> capillary and flat sheet membranes,<br />

particularly for haemodialysis, blood oxygenation<br />

and plasmapheresis. Products <strong>in</strong>clude the<br />

haemodialysis membrane families <strong>of</strong> DIAPES ® and<br />

PUREMA ® . Membrana also manufactures a variety<br />

<strong>of</strong> membranes used for filtration <strong>in</strong> various <strong>in</strong>dustries<br />

and applications and the Liqui-Cel ® contact<strong>ors</strong> for gas<br />

transfer as well as the Liqui-Flux ® modules for membrane<br />

filtration. www.membrana.com<br />

Miltenyi Biotec ............................................... Booth 2.40<br />

Miltenyi Biotec, a diversified biotechnology and medical<br />

device company, <strong>of</strong>fers the Cl<strong>in</strong>iMACS ® Cell Selection<br />

System. Based on MACS ® Technology, it can be<br />

used for cl<strong>in</strong>ical-scale magnetic enrichment <strong>of</strong> cells.<br />

Another exemplary cl<strong>in</strong>ical application represents TheraSorb<br />

Therapeutic Apheresis, which selectively<br />

removes pathogenic substances from the blood by immunoadsorption.<br />

www.miltenyibiotec.com<br />

Mitsubishi Pharma Europe .......................... Booth 1.10<br />

Mitsubishi Pharma Europe is the European Headquarters<br />

<strong>of</strong> one <strong>of</strong> Japan’s largest pharmaceutical companies,<br />

Mitsubishi Tanabe Pharma Corporation. Based <strong>in</strong><br />

London, Mitsubishi Pharma Europe is engaged <strong>in</strong> the<br />

cl<strong>in</strong>ical development <strong>of</strong> new drugs for the European<br />

markets. Mitsubishi Pharma Europe is conduct<strong>in</strong>g trials<br />

<strong>in</strong> Europe <strong>in</strong> the follow<strong>in</strong>g therapy areas; cardiovascular,<br />

diabetes, CNS and renal conditions. The staff<br />

<strong>in</strong>clude regulatory, QA, cl<strong>in</strong>ical, biostatistics, medical<br />

<strong>in</strong>formation, pharmacovigilance, pharmaceutical technology<br />

and market<strong>in</strong>g. www.mitsubishi-pharma.eu<br />

w w w . e r a e d t a 2 0 1 2 . o r g<br />

419<br />

EXHIBITORS


EXHIBITORS<br />

420<br />

49 th <strong>ERA</strong>-<strong>EDTA</strong> CONGRESS<br />

E X H I B I T O R S<br />

Nature Publish<strong>in</strong>g Group .............................Booth 1.P2<br />

Nature Publish<strong>in</strong>g Group (NPG) br<strong>in</strong>gs you lead<strong>in</strong>g<br />

scientific and medical research. Our portfolio comb<strong>in</strong>es<br />

the cont<strong>in</strong>ued excellence <strong>of</strong> Nature, its associated<br />

research and review journals, and over 50 lead<strong>in</strong>g<br />

academic and society journals <strong>in</strong> the life, physical<br />

and cl<strong>in</strong>ical sciences. Open access options are <strong>of</strong>fered<br />

through the academic and society journals. NPG also<br />

provides timely news content and, through Naturejobs,<br />

scientific career <strong>in</strong>formation. Visit the NPG stand<br />

P02 to pick up your free sample copies <strong>of</strong> Kidney International,<br />

Nature Reviews Nephrology and other<br />

NPG journals, subscribe at the conference rate, or f<strong>in</strong>d<br />

out about advertis<strong>in</strong>g opportunities <strong>in</strong> any NPG title.<br />

www.nature.pg<br />

NDT-ERBP-NDT-Educational ................... Booth 1.102<br />

Visit the <strong>ERA</strong>-<strong>EDTA</strong> booth to f<strong>in</strong>d <strong>in</strong>formation about<br />

the current activities, especially with regard to educational<br />

<strong>in</strong>itiatives and to the European Renal Best Practice.<br />

ERBP’s ma<strong>in</strong> purpose is to help <strong>in</strong>creas<strong>in</strong>g the<br />

implementation <strong>of</strong> European nephrology recommendations<br />

and guidance and to enhance the quality <strong>of</strong><br />

European and worldwide nephrology practice. ERBP<br />

has also created a set <strong>of</strong> patient <strong>in</strong>formation documents,<br />

<strong>in</strong> the belief that jo<strong>in</strong>t decisions, made together<br />

by physicians and well-<strong>in</strong>formed patients, are fundamental<br />

to obta<strong>in</strong> the best treatment for each <strong>in</strong>dividual<br />

renal patient.<br />

At the booth you can also collect a pr<strong>in</strong>ted copy <strong>of</strong> this<br />

congress’s Book <strong>of</strong> Abstracts, if you wish to have a paper<br />

version <strong>of</strong> it <strong>in</strong> addition to the one on CD.<br />

www.eraedta.org<br />

w w w . e r a e d t a 2 0 1 2 . o r g


MAY 24-27, 2012 PARIS, France<br />

E X H I B I T O R S<br />

Nephrokit ........................................................ Booth 1.28<br />

Nephtrokit was founded on December 2007, by Dr<br />

Mokhtar Chawki, skilled French Nephrologist on dialysis<br />

vascular access field. Based on the west suburb <strong>of</strong><br />

Paris. Nephrokit is an <strong>in</strong>novative start-up who deta<strong>in</strong>s<br />

4 validated patents for improv<strong>in</strong>g techniques <strong>of</strong> secur<strong>in</strong>g<br />

dialysis needle and reduc<strong>in</strong>g post dialysis time to<br />

clot <strong>of</strong> vascular access puncture sites. Nephrokit creates<br />

a breakthrough with new compressive device<br />

named “IRIS” ® for dialysis access puncture sites. Non<br />

exclusive agreement for IRIS distribution was signed<br />

with Bellco France and Belgium, Gambro France. The<br />

device is also sold <strong>in</strong> dialysis kits by Mölnylcke <strong>in</strong> Europe.<br />

Nephrokit is also seek<strong>in</strong>g to <strong>in</strong>troduce Iris ® <strong>in</strong> the doma<strong>in</strong><br />

<strong>of</strong> blood transfusion and is look<strong>in</strong>g for partners<br />

<strong>in</strong> this field. www.nephrokit.com<br />

Nikkiso Europe .............................................. Booth 2.75<br />

The Nikkiso group has been provid<strong>in</strong>g technologies<br />

and products <strong>in</strong> order to meet demands <strong>of</strong> our customer,<br />

the society and the times we live <strong>in</strong> for more<br />

than half a century. The Nikkiso Europe GmbH is our<br />

European entity based <strong>in</strong> Hanover/Germany and responsible<br />

for production and distribution <strong>of</strong> our excellent<br />

technologies to the EMEA (Europe, Middle East,<br />

Africa) region. Beyond production and distribution<br />

Nikkiso Europe is able to develop extracorporeal technologies<br />

<strong>in</strong> our Research and Development department.<br />

Overall the Nikkiso Europe GmbH is our clear<br />

commitment to Europe and our customers there. Nikkiso<br />

Europe GmbH – Our flexibility is your efficiency.<br />

www.nikkiso-europe.eu<br />

TYH<br />

R<br />

N<strong>in</strong>gbo Tianyi Medical Appliance .......... Booth 1.G15<br />

Established <strong>in</strong> 1998, N<strong>in</strong>gbo Tianyi Medical is specialized<br />

<strong>in</strong> produc<strong>in</strong>g hemodialysis blood l<strong>in</strong>e, blood<br />

tub<strong>in</strong>g sets for Cont<strong>in</strong>uous Renal Replacement Treatment<br />

(CRRT), Arterial venous fistula (AVF) needle,<br />

<strong>in</strong>fusion set, blood transfusion set ect. The company<br />

has achieved ISO 13485 certification. Products are under<br />

CE and CCC certificates. “Quality first, scientific<br />

management, s<strong>in</strong>cere and creditable service, customeroriented”<br />

is our bus<strong>in</strong>ess concept. www.tiany<strong>in</strong>b.com<br />

w w w . e r a e d t a 2 0 1 2 . o r g<br />

421<br />

EXHIBITORS


EXHIBITORS<br />

422<br />

49 th <strong>ERA</strong>-<strong>EDTA</strong> CONGRESS<br />

E X H I B I T O R S<br />

Nipro Europe................................................... Booth 2.14<br />

Nipro Europe has built its reputation on consistent<br />

high levels <strong>of</strong> quality and service <strong>in</strong> Europe. With its<br />

5 Bus<strong>in</strong>ess Units, we distribute products for hemodialysis<br />

(Renal Care), hospital consumables (Hospital<br />

Products), blood glucose diagnostics (Diabetes Care),<br />

oxygenat<strong>ors</strong> and accessories (Cardiopulmonary) and<br />

medical glass products (Pharmaceutical Solutions).<br />

Our priority is build<strong>in</strong>g long-term partnerships with<br />

each customer. This is accomplished by provid<strong>in</strong>g superior<br />

quality and value throughout the bus<strong>in</strong>ess <strong>in</strong><br />

addition to <strong>list</strong>en<strong>in</strong>g to customer needs and translat<strong>in</strong>g<br />

those needs <strong>in</strong>to specific products and services. We<br />

constantly thrive to create and <strong>of</strong>fer safe, high-quality<br />

products ensur<strong>in</strong>g a better quality <strong>of</strong> life.<br />

www.nipro-europe.com<br />

NKF USA ......................................................... Booth 2.26<br />

NKF USA <strong>of</strong>fers the nephrology community the latest<br />

science and practical tools through our cl<strong>in</strong>ical practice<br />

guidel<strong>in</strong>es, our free kidney screen<strong>in</strong>g programs,<br />

and our pr<strong>of</strong>essional memberships. Learn more about<br />

KDOQI (T), KEEP (T), and our scientific journals:<br />

AJKD, ACKD and JRN. F<strong>in</strong>d out about the new KDI-<br />

GO (R) Guidel<strong>in</strong>es that are be<strong>in</strong>g published this year<br />

<strong>in</strong>clud<strong>in</strong>g AKI, GN, Hypertension and Anemia.<br />

www.kidney.org<br />

Novartis Pharmaceuticals - Oncology ........ Booth 1.31<br />

Novartis is a global leader <strong>in</strong> oncology through strong<br />

research and development efforts and a broad portfolio<br />

<strong>of</strong> marketed products. Novartis Oncology discovers<br />

and develops <strong>in</strong>novative therapies <strong>in</strong>clud<strong>in</strong>g Glivec ®<br />

(imat<strong>in</strong>ib), Tasigna ® (nilot<strong>in</strong>ib), Af<strong>in</strong>itor ® (everolimus),<br />

Zometa ® (zoledronic acid), Femara ® (letrozole), Sandostat<strong>in</strong><br />

® LAR ® (octreotide acetate for <strong>in</strong>jectable suspension)<br />

and Exjade ® (deferasirox). Novartis Oncology<br />

has one <strong>of</strong> the broadest and most comprehensive<br />

pipel<strong>in</strong>es <strong>in</strong> the <strong>in</strong>dustry, currently with more than<br />

20 novel medic<strong>in</strong>es <strong>in</strong> development that target many<br />

therapeutically important prote<strong>in</strong>s to help address the<br />

unmet needs <strong>of</strong> patients. www.novartis.com<br />

w w w . e r a e d t a 2 0 1 2 . o r g


MAY 24-27, 2012 PARIS, France<br />

E X H I B I T O R S<br />

NxStage Medical ............................................ Booth 1.02<br />

NxStage is lead<strong>in</strong>g a movement to transform renal<br />

care. To make it simpler. To make it portable. To expand<br />

treatment options for cl<strong>in</strong>icians by overcom<strong>in</strong>g<br />

traditional barriers. NxStage is f<strong>in</strong>d<strong>in</strong>g itself at the<br />

forefront <strong>of</strong> dramatically improved renal care, thanks<br />

to <strong>in</strong>novative yet simple therapeutic solutions that<br />

benefit patients, caregivers, and society. For more <strong>in</strong>formation<br />

visit www.nxstage.com<br />

Otsuka Pharmaceuticals Europe ................. Booth 1.60<br />

Otsuka Pharmaceutical is a global healthcare company<br />

with the corporate philosophy: ‘Otsuka-people<br />

creat<strong>in</strong>g new products for better health worldwide.’<br />

The Otsuka Group is comprised <strong>of</strong> 151 companies and<br />

employs approximately 40,000 people <strong>in</strong> 23 countries<br />

and regions worldwide. Otsuka is committed to focus<strong>in</strong>g<br />

its research and development on <strong>in</strong>novative products<br />

and medical devices that address unmet medical<br />

needs, particularly <strong>in</strong> our specia<strong>list</strong> areas <strong>of</strong> renal, endocr<strong>in</strong>e,<br />

gastro-<strong>in</strong>test<strong>in</strong>al and central nervous system<br />

disorders. Come and visit Otsuka Europe at Stand 1.60<br />

on Level 1 at the Palais des Congrès de Paris, to learn<br />

more about Otsuka’s commitment to <strong>in</strong>novation and<br />

education <strong>in</strong> nephrology. www.otsuka-europe.com<br />

OUP Oxford University Press ...................... Booth 1.72<br />

Oxford University Press publishes some <strong>of</strong> most respected<br />

medical books and journals <strong>in</strong> the world <strong>in</strong>clud<strong>in</strong>g<br />

the Oxford Cl<strong>in</strong>ical Nephrology Series, and on<br />

behalf <strong>of</strong> the <strong>ERA</strong>-<strong>EDTA</strong> we publish the lead<strong>in</strong>g European<br />

journal Nephrology Dialysis Transplantation as<br />

well as CKJ (Cl<strong>in</strong>ical Kidney Journal). Visit our stand<br />

to browse books and to pick up free copies <strong>of</strong> the journals.<br />

www.oxfordjournals.org and www.oup.com.<br />

w w w . e r a e d t a 2 0 1 2 . o r g<br />

423<br />

EXHIBITORS


EXHIBITORS<br />

424<br />

49 th <strong>ERA</strong>-<strong>EDTA</strong> CONGRESS<br />

E X H I B I T O R S<br />

PakuMed .......................................................... Booth 1.36<br />

PakuMed medical products gmbh is a German company<br />

founded <strong>in</strong> 1990 specialized <strong>in</strong> the development,<br />

manufacture and worldwide distribution <strong>of</strong> special<br />

medical products. Highly qualified medical competence,<br />

flexibility and close cooperation with our customers<br />

as well as best service are our strong po<strong>in</strong>ts.<br />

Our product quality meets highest <strong>in</strong>ternational standard<br />

with reasonable prices. Besides port catheter systems<br />

and accessories, <strong>in</strong>novative products for Hemodialysis<br />

and Apheresis are designed to meet the needs<br />

<strong>of</strong> our clients and complete our product range.<br />

www.pakumed.de<br />

Pharmacosmos ................................................ Booth 2.13<br />

PHARMACOSMOS develops and markets medic<strong>in</strong>es<br />

for the treatment <strong>of</strong> iron deficiency. An <strong>in</strong>dependent<br />

pharmaceutical company with an ongo<strong>in</strong>g R&D programme,<br />

Pharmacosmos’ goal is to improve treatment<br />

options for healthcare pr<strong>of</strong>essionals and patients,<br />

by <strong>of</strong>fer<strong>in</strong>g <strong>in</strong>novative treatments - Pharmacosmos<br />

works with exclusive partners <strong>in</strong> more than 50 countries<br />

worldwide. Pharmacosmos holds the market<strong>in</strong>g<br />

authorisation for Mon<strong>of</strong>er ® (iron isomaltoside 1000),<br />

a treatment for iron deficiency anaemia that <strong>of</strong>fers<br />

patients with various iron needs the convenience <strong>of</strong><br />

high dose iron <strong>in</strong> one visit. Seventy million doses <strong>of</strong><br />

its second parenteral iron preparation CosmoFer ® (low<br />

molecular weight iron dextran) have already been adm<strong>in</strong>istered<br />

worldwide. www.pharmacosmos.com<br />

Physidia ............................................................ Booth 1.65<br />

Physidia is a French start-up. Its mission is the development<br />

and market<strong>in</strong>g <strong>of</strong> a daily hemodialysis system<br />

suitable for home use. The project was <strong>in</strong>itiated <strong>in</strong><br />

Lyon. In 2002-2005, the first tests systems were developed,<br />

which passed cl<strong>in</strong>ical trials. The S³ system will<br />

be marketed <strong>in</strong> 2013 <strong>in</strong> France. Ma<strong>in</strong> features are: premix<br />

dialysate; disposable l<strong>in</strong>es and pumps; simplified<br />

operations; truly portable; versatile modalities: SDHD<br />

and HDF, practice <strong>in</strong>spired by peritoneal dialysis.<br />

www.physidia.com<br />

w w w . e r a e d t a 2 0 1 2 . o r g


MAY 24-27, 2012 PARIS, France<br />

E X H I B I T O R S<br />

PosterSessionOnL<strong>in</strong>e -<br />

Poster Virtual Gallery ................................... Booth 1.24<br />

PosterSessionOnl<strong>in</strong>e is the world’s largest free-access<br />

medical poster resource - browse posters from <strong>ERA</strong>-<br />

<strong>EDTA</strong> and more than 50 other congresses onl<strong>in</strong>e at<br />

your leisure. Log on to the excit<strong>in</strong>g new <strong>ERA</strong>-<strong>EDTA</strong><br />

ONLINE POSTER FORUM to ask questions to the presenters,<br />

exchange ideas and network with colleagues.<br />

PosterSessionOnl<strong>in</strong>e has also provided all poster presenters<br />

with the opportunity to have their posters<br />

pr<strong>in</strong>ted and delivered free <strong>of</strong> charge to the congress<br />

venue, pick<strong>in</strong>g them up from the Takeda Hospitality<br />

Suite dur<strong>in</strong>g the meet<strong>in</strong>g.<br />

Log <strong>in</strong> and jo<strong>in</strong> the debate <strong>in</strong> the Era-Edta onl<strong>in</strong>e poster<br />

forum! www.postersessiononl<strong>in</strong>e.com<br />

Pronefro............................................................ Booth 1.96<br />

Pronefro, Produtos Nefrológicos, S.A. company was<br />

founded <strong>in</strong> 1983 and has its headquarters <strong>in</strong> Maia,<br />

located around 10km Porto <strong>in</strong> north <strong>of</strong> Portugal. We<br />

have a large experience has manufacture s<strong>in</strong>ce we<br />

have been work<strong>in</strong>g with medical devices and more<br />

specifically on dialysis products for over 25 years. We<br />

have <strong>in</strong> our range <strong>of</strong> products, bloodl<strong>in</strong>es, AV fistulas<br />

needles, dialysers, catheters, therapy chairs, tubes for<br />

esthetical use, diabetics shoes and others accessories.<br />

We work mostly with distribut<strong>ors</strong>, our product quality<br />

meets highest <strong>in</strong>ternational standards; the company is<br />

certified accord<strong>in</strong>g to EN ISO 9001 and EN ISO 13845.<br />

For more <strong>in</strong>formation please see our website<br />

www.pronefro.pt<br />

Roche ................................................................ Booth 2.52<br />

Headquartered <strong>in</strong> Basel, Switzerland, Roche is a<br />

leader <strong>in</strong> research-focused healthcare with comb<strong>in</strong>ed<br />

strengths <strong>in</strong> pharmaceuticals and diagnostics. Roche<br />

is the world’s largest biotech company with truly differentiated<br />

medic<strong>in</strong>es <strong>in</strong> oncology, virology, <strong>in</strong>flammation,<br />

metabolism and CNS. Roche is also the world<br />

leader <strong>in</strong> <strong>in</strong>-vitro diagnostics, tissue-based cancer<br />

diagnostics and a pioneer <strong>in</strong> diabetes management.<br />

Roche’s personalized healthcare strategy aims at provid<strong>in</strong>g<br />

medic<strong>in</strong>es and diagnostic tools that enable tangible<br />

improvements <strong>in</strong> the health, quality <strong>of</strong> life and<br />

survival <strong>of</strong> patients. For more <strong>in</strong>formation:<br />

www.roche.com<br />

w w w . e r a e d t a 2 0 1 2 . o r g<br />

425<br />

EXHIBITORS


EXHIBITORS<br />

426<br />

49 th <strong>ERA</strong>-<strong>EDTA</strong> CONGRESS<br />

E X H I B I T O R S<br />

Sandoz .............................................................. Booth 2.73<br />

Sandoz is a Novartis company with a reputation for<br />

quality go<strong>in</strong>g back to the 19 th century. Present <strong>in</strong> 130<br />

countries, our broad portfolio <strong>of</strong> affordable, high-quality<br />

medic<strong>in</strong>es is available to 90% <strong>of</strong> the world’s population.<br />

Sandoz Biopharmaceuticals, a specialized bus<strong>in</strong>ess<br />

with<strong>in</strong> Sandoz and Novartis, develops, produces<br />

and markets biopharmaceutical medic<strong>in</strong>es and active<br />

<strong>in</strong>gredients worldwide, and enjoys close synergies<br />

across the value cha<strong>in</strong> with other parts <strong>of</strong> the Novartis<br />

Group. Our decades <strong>of</strong> experience and significant<br />

<strong>in</strong>vestments have helped to position us as the pioneer<br />

and global leader <strong>in</strong> biosimilars. Our vision is to<br />

dramatically <strong>in</strong>crease patient access to essential highquality<br />

biopharmaceuticals, by consistently advanc<strong>in</strong>g<br />

this global leadership position. www.sandoz.com<br />

San<strong>of</strong>i Aventis Groupe .................................. Booth 2.79<br />

San<strong>of</strong>i a diversified global healthcare leader, focused<br />

on patients’ needs<br />

San<strong>of</strong>i has core strengths <strong>in</strong> the field <strong>of</strong> healthcare<br />

with growth platforms: emerg<strong>in</strong>g markets, human<br />

vacc<strong>in</strong>es, consumer healthcare, diabetes, <strong>in</strong>novative<br />

products and animal health. Through the acquisition<br />

<strong>of</strong> Genzyme, San<strong>of</strong>i has re<strong>in</strong>forced its footpr<strong>in</strong>t <strong>in</strong> biotechnology<br />

and rare diseases.<br />

San<strong>of</strong>i’ strategy is based on three key pr<strong>in</strong>ciples <strong>in</strong> order<br />

to deliver long-term susta<strong>in</strong>able growth: <strong>in</strong>creas<strong>in</strong>g<br />

<strong>in</strong>novation <strong>in</strong> Research & Development, seiz<strong>in</strong>g<br />

external growth opportunities, adapt to future challenges<br />

and opportunities.<br />

San<strong>of</strong>i:<br />

- More than 110,000 employees <strong>in</strong> 100 countries<br />

- 2011 net sales: €33.4 billion<br />

For more <strong>in</strong>formation: http://en.san<strong>of</strong>i.com/home.asp<br />

Savient Pharmaceuticals ............................... Booth 1.23<br />

Savient Pharma Ireland Limited, a wholly-owned subsidiary<br />

<strong>of</strong> Savient Pharmaceuticals, is a specialty biopharmaceutical<br />

company seek<strong>in</strong>g regulatory approval<br />

for KRYSTEXXA ® <strong>in</strong> the European Union for the treatment<br />

<strong>of</strong> refractory chronic gout. KRYSTEXXA is available<br />

<strong>in</strong> the European Union through a Named Patient<br />

Programme and is currently the only FDA approved<br />

product for this <strong>in</strong>dication <strong>in</strong> the United States.<br />

www.savient.com<br />

w w w . e r a e d t a 2 0 1 2 . o r g


MAY 24-27, 2012 PARIS, France<br />

E X H I B I T O R S<br />

Serumwerk Bernburg .................................... Booth 1.61<br />

The Serumwerk Bernburg Group is an <strong>in</strong>ternationally<br />

- renowned producer and supplier <strong>of</strong> medic<strong>in</strong>al<br />

products and medical devices for human and veter<strong>in</strong>ary<br />

use, based <strong>in</strong> Germany. The dialysis division is<br />

successfully active s<strong>in</strong>ce 1998 <strong>in</strong> Europe, Middle East,<br />

Asia and North Africa. It <strong>of</strong>fers a wide range <strong>of</strong> medical<br />

disposables for hemodialysis, e.g. VitaPES dialyzers,<br />

DiaCart & DiaBox bicarbonate cartridges, bloodl<strong>in</strong>es<br />

and IV solutions. The company is focused on<br />

<strong>of</strong>fer<strong>in</strong>g “Made <strong>in</strong> Germany” products to their worldwide<br />

clients. www.serumwerk.de<br />

Shire Pharmaceuticals ................................... Booth 2.01<br />

Shire shares the vision <strong>of</strong> nephrology practitioners to<br />

place the best <strong>in</strong>terest <strong>of</strong> patients at the heart <strong>of</strong> everyth<strong>in</strong>g<br />

we do. The commitment <strong>of</strong> Shire is to enable<br />

people with life-alter<strong>in</strong>g conditions to lead better lives.<br />

In the field <strong>of</strong> nephrology, Shire supports research<br />

which improves understand<strong>in</strong>g <strong>of</strong> renal science, kidney<br />

health awareness and education <strong>in</strong> renal units<br />

Products <strong>in</strong>clude Fosrenol ® , a non-calcium, non-res<strong>in</strong><br />

phosphate b<strong>in</strong>der for the management <strong>of</strong> hyperphosphataemia.<br />

www.shire.com<br />

S<strong>in</strong>ed ................................................................. Booth 1.57<br />

S<strong>in</strong>ed is an <strong>in</strong>ternational medical computer solutions<br />

specia<strong>list</strong>, focused exclusively on the design, manufacture,<br />

<strong>in</strong>stallation and ma<strong>in</strong>tenance <strong>of</strong> remote monitor<strong>in</strong>g,<br />

cl<strong>in</strong>ical record and data collection systems. S<strong>in</strong>ed<br />

not only <strong>of</strong>fers lead<strong>in</strong>g expertise as a pioneer <strong>of</strong> IT <strong>in</strong><br />

nephrology, but is uniquely customer focused, committed<br />

to multi-brand compatibility that protects exist<strong>in</strong>g<br />

<strong>in</strong>vestments while provid<strong>in</strong>g fully-customised, scalable<br />

solutions that meet all a customer’s needs cost-effectively.<br />

Renowned for close customer service, S<strong>in</strong>ed works<br />

with medical, IT and adm<strong>in</strong>istrative staff to <strong>in</strong>crease<br />

efficiency and reduce risks, simultaneously improv<strong>in</strong>g<br />

stock and f<strong>in</strong>ance management to achieve substantial<br />

sav<strong>in</strong>gs and reliable revenue. www.s<strong>in</strong>ed.it<br />

w w w . e r a e d t a 2 0 1 2 . o r g<br />

427<br />

EXHIBITORS


EXHIBITORS<br />

428<br />

49 th <strong>ERA</strong>-<strong>EDTA</strong> CONGRESS<br />

E X H I B I T O R S<br />

Soludia Maghreb ............................................ Booth 2.65<br />

Based <strong>in</strong> Morocco s<strong>in</strong>ce 1998, Soludia Maghreb pharmaceutical<br />

laboratory is the lead<strong>in</strong>g manufacturer<br />

specialized <strong>in</strong> produc<strong>in</strong>g haemodialysis solution and<br />

powder products with a French licence. We provide<br />

excellent service to our customers. Our company is<br />

certified ISO 9001, ISO 13485, CE 120 labelled products,<br />

ISO 17025 <strong>in</strong> progress<br />

Our range <strong>of</strong> products :<br />

- Bicarbonate liquid, Bicarbonate powder for Gambro<br />

generator, for Fresenius generator and for Bellco generator.<br />

- 5 liters acid bag, acetate free acid, acid central with<br />

1000 liters Tank.<br />

- water analysis for haemodialysis<br />

We have the big part <strong>of</strong> the Moroccan market shares.<br />

We have been export<strong>in</strong>g our products to West Africa.<br />

We started export<strong>in</strong>g our products to Europe.<br />

For additional <strong>in</strong>formation on our company and products,<br />

please log on our website www.soludia.ma<br />

Takeda Pharmaceuticals Europe ......... Booth P01+P02<br />

Takeda is a research-based global pharmaceutical<br />

company committed to striv<strong>in</strong>g towards better health<br />

for patients worldwide through lead<strong>in</strong>g <strong>in</strong>novations<br />

<strong>in</strong> medic<strong>in</strong>e. Takeda is renowned for its expertise and<br />

is dedicated to build<strong>in</strong>g on its success as a leader and<br />

preferred partner <strong>in</strong> the pharmaceutical <strong>in</strong>dustry.<br />

Takeda’s vision is to embody worldwide pharmaceutical<br />

leadership through <strong>in</strong>novation, culture and growth,<br />

guided by an unwaver<strong>in</strong>g commitment to significantly<br />

improve the lives <strong>of</strong> patients. www.takeda.eu<br />

TauroPharm ..................................................... Booth 1.43<br />

TauroPharm GmbH is a life science company specialized<br />

<strong>in</strong> antimicrobial medical devices. One <strong>of</strong> the<br />

company’s core <strong>in</strong>terests is to <strong>of</strong>fer a safe and effective<br />

technology for lock<strong>in</strong>g central venous access devices<br />

(catheters and ports). TauroLock, a non-antibiotic<br />

lock solution, which is capable <strong>of</strong> dramatically reduc<strong>in</strong>g<br />

catheter related blood stream <strong>in</strong>fections (CRBSI) is<br />

free <strong>of</strong> side effects. TauroLock is highly effective <strong>in</strong><br />

eradicat<strong>in</strong>g bacteria and fungi and has been successfully<br />

tested on more than five hundred organisms, <strong>in</strong>clud<strong>in</strong>g<br />

multiresistant forms such as MRSA and VRE.<br />

It is to be used <strong>in</strong> dialysis, oncology, <strong>in</strong>tensive care and<br />

parenteral nutrition. To improve catheter patency Tau-<br />

w w w . e r a e d t a 2 0 1 2 . o r g


MAY 24-27, 2012 PARIS, France<br />

E X H I B I T O R S<br />

roLock products conta<strong>in</strong> 4% citrate and/or hepar<strong>in</strong><br />

(TauroLock, TauroLock-Hep100, TauroLock-<br />

Hep500) and/or urok<strong>in</strong>ase (TauroLock-U25.000).<br />

www.tauropharm.de<br />

Terumo BCT ..................................................Booth 1.98B<br />

CaridianBCT and Terumo Transfusion have united to<br />

become Terumo BCT, a global leader <strong>in</strong> blood component<br />

and cellular technologies. We believe <strong>in</strong> the potential<br />

<strong>of</strong> blood and cell therapies to do even more for<br />

the world than they do today. As we strive to make<br />

even safer, higher-quality transfusions available, we<br />

can help our customers br<strong>in</strong>g even more treatment options<br />

to patients with advanced blood therapies and<br />

we can help researchers develop cell therapies that<br />

may fundamentally improve health care.<br />

www.terumobct.com<br />

BRAHMS GmbH,<br />

Part <strong>of</strong> Thermo Fisher Scientific ................ Booth 1.113<br />

Thermo Fisher Scientific specialises <strong>in</strong> <strong>in</strong>novative<br />

products that facilitate earlier diagnosis <strong>of</strong> diseases<br />

and better control <strong>of</strong> therapy, thus enabl<strong>in</strong>g doct<strong>ors</strong> to<br />

provide more efficient and economic patient care.<br />

Major fields <strong>of</strong> activity are diagnosis <strong>of</strong> <strong>in</strong>fectious and<br />

thyroid diseases, cardiology and pneumology as well<br />

as sepsis, tum<strong>ors</strong>, and Down’s syndrome.<br />

www.thermoscientific.com/brahms<br />

Tianj<strong>in</strong> Denny Tech Co. ..............................Booth 1.63B<br />

We are pr<strong>of</strong>essional manufacturer <strong>of</strong> dialysis product,<br />

We hold 1000 m2 clean room and completed foundation<br />

complementation. We possess advanced <strong>in</strong>jection<br />

mach<strong>in</strong>e, extrud<strong>in</strong>g mach<strong>in</strong>e, high frequency heat<br />

seal<strong>in</strong>g mach<strong>in</strong>e, ETO sterilization equipment, semiproduct<br />

automatic assembl<strong>in</strong>g mach<strong>in</strong>e, large-scale<br />

central air condition<strong>in</strong>g system and cool<strong>in</strong>g unit. The<br />

composition delivers the totally enclosed production<br />

process from raw material <strong>in</strong>vestment to the end product.The<br />

blood tub<strong>in</strong>g and arterial venous fistula needle<br />

was sales <strong>in</strong> world wide and we have passed CE and<br />

ISO13485 quality certification.<br />

w w w . e r a e d t a 2 0 1 2 . o r g<br />

429<br />

EXHIBITORS


EXHIBITORS<br />

430<br />

49 th <strong>ERA</strong>-<strong>EDTA</strong> CONGRESS<br />

E X H I B I T O R S<br />

Toray ................................................................ Booth 1.49<br />

Toray is a lead<strong>in</strong>g manufacturer <strong>of</strong> synthetic fibers and<br />

dedicated to the development <strong>of</strong> dialysis products under<br />

its corporate slogan, “Innovation by Chemistry”.<br />

Toray supports high quality and advanced medical<br />

care with our biocompatible polymethylmethacrylate<br />

dialyzer, FILTRYZER, high flux polysulfone dialyzer,<br />

TORAYSULFONE & TORAYLIGHT, and dialysis mach<strong>in</strong>e,<br />

TR-8000.<br />

www.toray-medical.com/en/<strong>in</strong>dex.html<br />

Turkish Society <strong>of</strong> Nephrology ................ Booth 1.G12<br />

When the Turkish Society <strong>of</strong> Nephrology (TSN) was<br />

founded <strong>in</strong> Istanbul forty one years ago <strong>in</strong> 1970, it co<strong>in</strong>cided<br />

with that <strong>of</strong> many <strong>of</strong> the Western European<br />

Nephrology Societies. Currently, TSN has 411 active<br />

members and 11 work<strong>in</strong>g groups also 8 branches with<br />

their own separate memberships <strong>in</strong> Istanbul, Izmir,<br />

Kayseri, Antalya, Bursa, Konya, Adana and Ankara.<br />

Turkish membership has actually reached 273 <strong>in</strong> ISN<br />

& 294 <strong>in</strong> <strong>ERA</strong>-<strong>EDTA</strong> (6th largest membership). TSN<br />

has <strong>in</strong>creased its patient awareness activities this year<br />

and on the Kidney Day, TSN Activities consisted <strong>of</strong><br />

a large variety from Banners <strong>in</strong> Football Matches to<br />

Newspaper Advertisements, TV Ads, Stands <strong>in</strong> Shopp<strong>in</strong>g<br />

Malls, Press Brief<strong>in</strong>gs School Visits and handouts<br />

<strong>in</strong> Nephrology Centers. www.tsn.org.tr/en/<br />

Vifor Fresenius Medical Care<br />

Renal Pharma .........................................Booth 2.22+2.23<br />

Vifor Fresenius Medical Care Renal Pharma Ltd. is a<br />

strategic partnership between Vifor Pharma and Fresenius<br />

Medical Care. The nephrology company develops<br />

and commercialises <strong>in</strong>novative and high-quality<br />

products to improve the lives <strong>of</strong> patients suffer<strong>in</strong>g<br />

from chronic kidney disease worldwide. The products<br />

<strong>in</strong>clude Ven<strong>of</strong>er ® and Fer<strong>in</strong>ject ® <strong>in</strong> the field <strong>of</strong> dialysis<br />

and pre-dialysis (CKD stage III – V) as well as PA21, a<br />

novel iron-based phosphate b<strong>in</strong>der.<br />

www.viforpharma.com/en/About-Vifor/bus<strong>in</strong>esses.<br />

php<br />

w w w . e r a e d t a 2 0 1 2 . o r g


MAY 24-27, 2012 PARIS, France<br />

E X H I B I T O R S<br />

W I C H T I G E D I T O R E<br />

MEDICAL PUBLISHER<br />

Wichtig Editore ................................................Booth 1P3<br />

Wichtig Editore Medical publisher began its activity<br />

<strong>in</strong> 1977, dedicat<strong>in</strong>g passion and competence to the<br />

publication <strong>of</strong> widely appreciated scientific journals -<br />

focus<strong>in</strong>g on nephrology, dialysis and transplantation<br />

– mostly <strong>in</strong>dexed <strong>in</strong> important bibliographic databases.<br />

The Editorial Board <strong>of</strong> these outstand<strong>in</strong>g journals<br />

acknowledge well-known lead<strong>in</strong>g scientists and, it is<br />

also thanks to their contributions, that Wichtig Editore’s<br />

titles are <strong>in</strong>creas<strong>in</strong>gly appreciated worldwide.<br />

Also, to be up-to-date, Wichtig Editore Medical Publisher<br />

is work<strong>in</strong>g to make its publications available as<br />

e-pubs for tablets and smartphones<br />

Websites: www.artificial-organs.com - www.<br />

jnephrol.com - www.vascular-access.<strong>in</strong>fo - www.<br />

wichtig-publisher.com/g<strong>in</strong><br />

Wisepress ...................................................... Booth 1.G18<br />

Wisepress.com, Europe’s lead<strong>in</strong>g conference bookseller,<br />

has a complete range <strong>of</strong> relevant books and journals<br />

which can be purchased at the stand or, if you would<br />

rather not carry them, posted to you - Wisepress will<br />

deliver worldwide. We also have a comprehensive<br />

medical and scientific onl<strong>in</strong>e bookshop with great <strong>of</strong>fers.<br />

www.wisepress.com<br />

WS Far Ir Medical ....................................... Booth 1.63A<br />

We are the pioneer <strong>in</strong> Far-Infrared medical equipment<br />

<strong>in</strong>dustry, and have been manufactur<strong>in</strong>g the FIR Therapy<br />

Unit for 20 years; our product WS Far-Infrared<br />

Therapy Unit is an essential tool for vascular access<br />

care <strong>in</strong> the hemodialysis centers all across Taiwan. In<br />

March 2007, the cl<strong>in</strong>ical evidence, “Far Infrared Therapy:<br />

a Novel Treatment Improv<strong>in</strong>g Access Blood Flow<br />

and Unassisted Patency <strong>of</strong> Arteriovenous Fistula <strong>in</strong><br />

Hemodialysis Patients” was published <strong>in</strong> the Journal<br />

<strong>of</strong> American Society <strong>of</strong> Nephrology shows that Far-<br />

Infrared Therapy can effectively improve the access<br />

blood flow and unassisted patency <strong>of</strong> AV Fistula <strong>in</strong><br />

hemodialysis patients. www.far-<strong>in</strong>frared.com.tw<br />

w w w . e r a e d t a 2 0 1 2 . o r g<br />

431<br />

EXHIBITORS

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!